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ABSTRACT
The observations that substance P (SP) is localized in
the anterior pituitary gland (AP) and is regulated by the
hormonal status of the animal, as well as the demonstration
of SP binding sites in the AP, have led to the idea that SP
may participate in the regulation of AP function. Numerous
and sometimes contradictory reports of SP effects on AP
hormone secretion, particularly on luteinizing hormone (LH),
left the question of whether SP acts directly at the level of
the AP to regulate LH secretion still unanswered. To
investigate a possible physiological function of SP in the
AP, the effects of exogenous SP on LH secretion from AP cells
from adult and prepubertal male and female rats in short term
cuI ture were studied. It was found that SP (100nM-l
significantly stimulates LH release in cultured AP cells and
that this effect varies as a function of age and sex. SP has
no significant effect on LH release from AP cells of male and
female prepubertal rats. After day 30 a sharp increase in the
response to SP occurs in both sexes. This level of
responsiveness continues through adulthood in AP cells from
the female rat. In contrast, AP cells from male rats failed
to respond during adulthood (over 50 days of age) but were
i i
highly responsive during the peripubertal period (30-35
days). The possibility that the responsiveness to SP is
influenced by the endocrine status of the animal was
investigated by exposing AP cells from responding animals to
androgens in vivo and in vitro. It was found that AP cells
from female rats treated with androgen were less responsive
to 100nM SP but did respond at higher doses of SP. SP effects
on AP function were further analyzed in experiments using
radioligand binding assays to assess possible changes in SP
receptor number or affinity as related to age and sex. In AP
membranes from female rats, maximum binding is 8-fold higher
(Bmax=4. 2 pmol/mg membrane protein) than in AP membranes from
male rats (Bmax=560fmol/ mg membrane protein). These studies
suggest a role for SP as a secondary regulator of LH
secretion with possible physiological significance for
reproductive function.
i i i
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INTRODUCTION
Discovery, Iso1ation
of Substance P and Characterization
Substance P (SP) is a peptide that was first detected in
extracts of equine brain and intestine in 1931 by von Euler
and Gaddum (von Euler and Gaddum 1931). While attempting to
demonstrate release of acetylcholine from intestine, they
found that a standardized preparation of intestinal extract,
designated "P" for preparation, caused a transient
hypotension when injected into anesthetized rabbits and
stimulated contraction in isolated jejunum in vitro. The
contraction of intestinal tissue was not inhibited by
atropine and after elimination of other compounds known to
cause intestinal contraction it was concluded that these
effects were due to an unknown substance. This substance in
the preparation that caused the activity was named subtance
P. It was determined that the substance had a low molecular
weight and the biological activity was destroyed by
proteolytic digestion (von Euler 1936). A study of extracts
from different organs showed that SP was present in
significant quantities in the brain. Later studies by Pernow
O,i
(1953), extensivly mapping the substance in various tissues,
revealed a high concentration of the substance in the
hypothalamus and in the dorsal horn of the spinal cord.
It was not until 1967, in the course of an attempt to
purify a corticotropin releasing factor from bovine
hypothalamic extracts, that Leeman and Hammerschlag reported
the discovery of a peptide which caused salivation when
injected intravenously (Leeman and Hammerschlag 1967). This
sialogogic peptide was subsequently characterized as SP. The
peptide was purified by Leeman and Chang (1970), and the
amino acid sequence was determined to be H-Arq-Pro-Lys-Pro-
Gln-Gln-Phe-Phe-Gly- Leu -Met -NH2 (Chang et al 1971).
Additional studies done by Studer et al (1973) and Carraway
and Leeman (1979) confirmed the sequence and the identity
between the sialogogic peptide and SP.
In the intervening years between the discovery of SP and
its purification and sequencing, Espamer et al (1949),
discovered active components of octopus salivary glands with
hypotensive, sialogogic and spasmogenic activity that could
not be attributed to other known substances. These active
principles, eledoisin and physaleamin and kassinin, were
purified, characterized and sequenced and found to share
similar biological activity and chemical structure including
the C-terminal sequence -Phe-X-Gly-Leu-Met-NH2 (Anastasi and
Espamer 1970; Anastasi 1977). Because the active peptides
showed a characteristic fast onset of action on tissues of
the gut, the name tachykinin, which literally means " fast
movement" , was given to the peptides of the group.
Until recently SP was the only known mammalian
tachykinin, however in recent years two other mammalian
tachykinins have been isolated. After the development of an
RIA for kassinin, it was found that extracts of spinal cord
contained abundant kassinin-like immunoreactivity, which was
attributed to a novel peptide. This peptide was named
substance K, and was sequenced by Kimura et al (1983). At
about this time, another group, Kangawa et al (1983) in
search of novel neuropeptides sequenced a peptide they called
neuromedin K, which has also been called neurokinin B, and a
peptide they called neuromedin L which proved to be substance
K. Table 5 illustrates the amino acid sequences of some of
the tachykinins refered to above.
The three mammalian tachykinins, SP, SK and neuromedin K
are derived from two different genes which are structurally
related. Nawa and coworkers (1983) cloned a cDNA encoding SP
and discovered that the cDNA cloned from bovine striatum
encoded not only SP but also encoded subtance K in the same
precursor. This was called the preprotachykinin-A (PPT-A)
gene. Krause et al (1987) isolated a rat PPT cDNA which
structurally resembles bovine PPT-A cDNA. The PPT-B gene
encodes the precursor for neuromedin K. Analysis of these
cDNAs and the proteins they encode made possible the study of
the regulation of PPT gene expression.
Receptors
As with other neurotransmitter and peptide hormones
there is evidence that SP exerts its diverse effects by
interacting with specific receptors located on the plasma
membrane of the target cell. The potency differences among
the tachykinins and their fragments in bioassays on mammalian
tissues led to the concept that multiple subtypes of SP
receptors existed in those tissues. Further pharmacological
studies suggested the presence of at least three distinct
types of binding sites, each of which exhibited a
preferential affinity for one of the three known mammalian
tachykinins. The current nomenclature has classified
mammalian tachykinin receptors as NK1, NK2 and NK3 receptor
subtypes, based on whether the preferential endogenous ligand
is SP, SK or neurokinin B (neuromedin (Henry 1987; Regoli
et al 1988). These tachykinin binding sites are saturable, of
low capacity and high affinity (Burcher 1988; Regoli 1987;
Quirion 1985; Cascieri 1983). However it must be kept in mind
that binding sites are not always receptors, and in comparing
data from radio ligand binding and pharmacological effects it
has become clear that in vitro, one exogenously applied
tachykinin can act as an agonist at another s receptor. If
two or three tachykinin receptor subtypes are present in an
organ, two or three different processes could contribute to
the final biological effect.
Receptor characterization of most of the classical
transmitters has relied on the use of specific high affinity
antagonists to distinguish between receptor subtypes. For the
tachykinins, unfortunately, as with many peptides, no
suitable antagonists have been discovered. The SP antagonists
which have been reported are neither specific nor high
affinity and frequently have agonist properties. Therefore,
the study of tachykinin receptor subtypes has been carried
out using the natural, but nonselective agonists. Recently,
selective agonists for the tachykinin receptors have provided
pharmacological tools for the characterization of receptor
subtypes (Regoli 1988). Specific chemical modifications and
amino acid replacements within the SP molecule or its
fragments increased the selectivity for the NK1, NK2 and NK3
receptors. These selective agonists have made it possible to
distinguish between tachykinin receptor subtypes involved in
physiological function. For example, the NK1 selective
compound, (Pro9 Met(02)11)SP is a very potent promoter of
salivary secretion while the selective agonists for the NK2
and NK3 receptors, (Nle10)-NKA(4-10) and (MePhe7)NKB
respectively, are completely inactive. This would imply that
SP action on NK1 receptors mediates salivary secretion.
Two of the tachykinin receptors, NK1 and NK2 are thought
to be coupled to a G-protein that activates a phosphatidyl-
inositol, calcium second message pathway (Buck 1986). The
amino acid sequences of these two receptors have recently
been described on the basis of the sequence analysis of the
molecular clones (Yokota 1989). This information was
confirmed when the expressed receptor selectively bound SP.
The amino acid sequence shows similarities to other G-protein-
coupled receptors and possesses seven membrane spanning
domains. The amino- and carboxyl-terminal regions differ
between the two receptors which may contribute to their
specificities.
Distribution and Physiology Bypothalamic-the
Pituitary Axis
SP was first isolated and characterized from extracts of
bovine hypothalamus and is found in high concentrations in
that tissue. Since neuroendocrine cells in the hypothalamus
which synthesize and secrete regulatory peptides are so
important in the regulation of anterior pituitary funtion,
many workers postulated that hypothalamic SP might influence
the secretion of anterior pituitary hormones. In addition SP
is present in the anterior pituitary itself which raises the
possibility that SP could be released from cells within the
anterior pituitary to act in a paracrine or autocrine way to
influence anterior pituitary function.
in the Bypothal.amus .
Hypothalamic regulation of anterior pituitary function
can occur at many sites, including neural afferent inputs to
the hypothalamus, the neuroendocrine cells, hypothalamic
interneurons and the neural capillary interface of the median
eminence.
SP producing neurons in the hypothalamus are typical in
location and morphology to other neurosecretory neurons which
influence anterior pituitary function. Hypothalamic-peptide-
producing neurons exhibit a common organizational pattern in
that most of their cell bodies are located in the
paraventricular nucleus, the periventricular area or the
arcuate nucleus, with smaller populations of neurons in the
medial preoptic area (Weiner 1988). Cell bodies containing SP
are found in the arcuate nucleus and medial preoptic area in
the rat (Ljungdahl 1978). Immunohistochemical studies
identified SP containing fibers in the stria terminalis which
projects to neuroendocrine cells in the hypothalamus
(Palkovits 1979). Neuronal fibers which stain for SP are
found in the same regions that contain SP-positive staining
cells. These fibers are especially prominent in the medial
preoptic area.
The external lamina of the median eminence is the site
of termination of neuroendocrine axons onto capillaries of
the hypothalamic-hypophyseal portal system. SP-positive
fibers are found in the external lamina of the median
eminence in the monkey and in the rat (Hokfelt 1978; Tsuruo
1983). These fibers appear to terminate on the pericapillary
space of the portal vessels. More recently, palkovits et al
(1989) demonstrated that SP containing nerve fibers in the
median eminence of the rat originate in the ventromedial
arcuate nucleus. Such findings support the possibility that
SP could be secreted from neuroendocrine cells into the
portal circulation and eventually to the anterior pituitary,
although attempts to measure SP in the portal blood have been
unsuccessful.
There is much evidence which suggests that SP may
participate in the control of gonadotropin secretion by
acting at the hypothalamic level. Nerve terminals in the
medial preoptic area of the mouse which contain SP appear to
synapse on GnRH cell bodies (Hoffman 1985). SP also increases
GnRH release from medial basal hypothalamus in vitro,
resulting in LH release from the pituitary. Estrogen but not
progesterone is involved in the release of GnRH by SP
(Ohtsuka 1987). Additionally, lateral ventricular injection
of an antiserum to SP or an analogue of SP with antagonistic
properties has been shown to significantly suppress LH levels
in the circulation (Dees 1985). However, studies of this type
involve many potential problems including the specificity of
the action of SP and the possibility that the observed
effects represent a summation of actions at multiple sites.
Hypothalamic SP-containing neurons in rats display a sex
difference in appearance, and in females the ultrastructural
morphology of the perikarya varies during the estrous cycle
(Tsuruo 1987). At diestrus, the termimals contain large cored
vesicles, whereas at estrus they contain small clear
vesicles. These studies further demonstrated that SP-
containing cell bodies in the arcuate nucleus increase in
number during the early stages of pregnancy but decrease in
number at the end of pregnancy and during lactation. Decrease
in synthesis or increase in release from the nerve terminals
in the median eminence may be the cause of this decrease in
immunoreactivity in the perikarya and cell bodies. Frankfurt
et al (1986), found alterations in SP concentrations in
estrogen concentrating areas of rat brain, particularly in
the medial preoptic area and the medial ventral hypothalamus,
throughout the estrous cycle. The study found that SP
concentrations were significantly higher at diestrus and
estrus than at proestrus when LH levels are highest.
It is tempting to theorize from these studies that SP
may be involved in the hypothalamic-hypophyseal-gonadal axis,
however, it is not clear from the results of these studies
whether SP is involved in regulation of AP hormone secretion
or whether SP may be involved in other events that take place
during the estrous cycle. More direct tests of SP effects on
the neurosecretory cells of the hypothalamus are needed to
clarify the putative role of SP in neuroendocrine regulation.
in the Anterior Pituitary
The possibility that SP, originating in the anterior
pituitary, acts there in a paracrine or autocrine way to
influence anterior pituitary secretion is supported by
several kinds of evidence. SP is present in the anterior
pituitary glands of rats, guinea pigs, monkeys and humans as
determined by immunocytochemistry and/or radioimmunoassay of
whole AP extracts. The immunoreactive SP found in rat
anterior pituitary has been found to behave identically to
synthetic SP on high pressure liquid chromatography. In
regard to the question of what cell types contain SP, Morel
and coworkers (1982) found that SP immunoreactivity was
present in the lactotroph and gonadotroph in both prepubertal
and adult rats. De palatis et al (1982), using a different
immunocytochemical technique, found that SPLI was located in
a subpopulation of thyrotrophs in the guinea pig. It has been
demonstrated that SP can be released from hemipituitaries
incubated in vitro with high potassium concentrations (Aronin
et al 1984). Whether SP is released in vivo under
physiological conditions, a prerequisite for a paracrine role
for SP, remains to be determined. Evidence to support the
idea that SP is synthesized in the anterior pituitary was
provided by Jonassen et al (1987) who demonstrated the
presence of PPT-A mRNA in rat anterior pituitary.
The SP content in the anterior pituitary is not constant
but is highly subject to variation by hormonal treatment.
Studies by Aronin et al (1984) revealed that the
concentration of SP in the rat anterior pituitary is affected
by thyroid status. SP is increased in the anterior
pituitaries of hypothyroid rats and is decreased after
treatment with excess T4. Whether the increase in the
anterior pituitary SP content after thyroidectomy is related
to an increase in the number of thyrotrophs that contain SP
or to an increase in SP per cell is not known. However, since
T4 causes a marked decrease in SP content within two days it
is unlikely that this is due to a decrease in the number of
thyrotrophs suggesting that thyroid hormones may have an
effect on SP content in the anterior pituitary unrelated to
thyrotrope number. Alternatively, SP contained in lactotrophs
or gonadotrophs could also respond to T4.
Expression of PPT-A gene in rat anterior pituitary is
increased after thyroidectomy and decreased by administration
of thyroid hormone (Jonassen 1987). Jonassen et al
demonstrated the presence in the anterior pituitary of
another mammalian tachykinin, SK. SP and SK concentrations
are regulated in parallel by thyroid hormone status. These
results strongly suggest that SP and SK are synthesized in
the rat anterior pituitary.
There are also age, sex and gonadal steroid related
changes in SP concentrations in the anterior pituitary. There
is a significant difference in the APSP concentrations of
adult male and female rats. Males have 2-3 fold more APSP
than female rats (De palatis 1982, Abstract; Coslovsky 1984).
This sex related difference in SP levels is dependent upon
the age of the rat in that no significant difference in APSP
levels between prepubertal males and females is found,
whereas at two months of age, male APs had significantly
higher concentrations of SP. Neonatal exposure to
testosterone (Yoshikawa 1983) appears to be important in
determining the male levels of APSP, as gonadectomy of older
rats did not significantly lower APSP concentrations.
Further insight into the importance of gonadal steroids
in mediating the changes in APSP came with reports by
Coslovsky (1984) and DePalatis (1985) which showed that
ovariectomy of adult female rats causes a significant
increase in SP content, whereas administration of estrogen to
gonadectomized rats of both sexes causes a reduction.
Administration of the 5-a-reduced metabolite of testosterone,
5-a-dihydrotestosterone (DHT), markedly increases SP
concentrations in both gonadectomized sexes. However
testosterone is ineffective in elevating SP concentrations in
the AP suggesting the possibility that aromatization of
testosterone to estradiol may attenuate the response to the
portion of testosterone that is reduced to DHT.
It is not known whether gonadal steroids act directly at
the level of the AP to mediate changes in SP concentrations
in vivo. The AP has receptors for androgens, including DHT,
and estrogen as well as 5-a-reductase activity, but does not
have the aromatase enzyme. It is possible, therefore that
gonadal steroids could act directly at the AP level.
Sensitivity to gonadal steroids requires a maturational
process and becomes evident during the juvenile stage of
development (Coslovsky 1985). In contrast, hypo- or
hyperthyroidism alter SP levels in the anterior pituitary of
infantile rats to the same extent as in adult rats. The
maturation process required for gonadal steroid regulation of
SP concentrations could be a result of the reported changes
in sensitivity to testosterone and estrogen during
development (Negro-Vilar 1973) . This report shows that the
sensitivity of the hypothalamic-pituitary unit to the
negative feedback effect of testosterone declines during
development, whereas sensitivity to T4 may not undergo such
changes. DHT administration to hypothyroid infantile rats
leads to a significant increase in SP content in the anterior
pituitary, suggesting that thyroid hormones may somehow
regulate the timing of the sensitivity to androgens in the
AP. An alternative explanation of this additive effect of DHT
is that androgenic hormones are known to decrease T4 binding
capacity of thyroid binding globulins resulting in
abnormalities of the plasma transport of T4 , and perhaps 
exacerbation of the existing hypothyroid condition which is
not specifically related to the action of DHT on the anterior
pituitary.
There is also a clear sex difference in anterior
pituitary PPT-A mRNA levels, and gonadal steroids appear to
play a regulatory role (Jonassen et al 1988; Brown et al
1990). In female rats androgen increases whereas estradiol
decreases anterior pituitary PPT-A mRNA. Normal male rats
have higher anterior pituitary PPT-A mRNA abundance yet
appear to be less sensitive to gonadectomy than females,
suggesting that either estrogen is the important gonadal
steroid regulating SP concentrations, or, as Yoshikawa and
Hong suggested, neonatal exposure to testosterone is the
determining factor in adult male APSP concentrations.
Effects on Anterior Pituitary Hormone Release
Numerous reports suggest that SP may affect anterior
pituitary hormone release. The effects of SP in many reports
vary depending on the site, route or method of administration
of the peptide. Tables 1-4 summarize the reported effects.
Intravenous and intracerebroventricular injection of SP in
rats stimulates prolactin release (Vijayan 1979; Kato 1976).
In vitro incubation of hemipituitaries with SP also produces
an increase in prolactin release.
SP also alters growth hormone release although its
effects are inconsistent. Intravenous injection (vijayan
1979; Rivier 1977) of synthetic SP increased plasma
concentrations of growth hormone. Similarly, injection of SP
into the third ventricle of conscious, normal or
ovariectomized rats resulted in an increase in plasma growth
hormone (Vijayan 1980). In contrast, reduced levels of growth
hormone have been reported with SP injection into the lateral
ventricle in urethane anesthetized male rats (Chihara 1978).
The studies reported above do not address the question
of whether the effects of SP were directly on the anterior
pituitary or on the hypothalamus, nor do they suggest whether
SP effects require an intermediate mediator. Chihara et al
(1978) proposed that SP injected intraventricularly acts via
somatostatin because pretreatment with somatostatin antiserum
abolished the SP effect. Further, in a separate report
(Sheppard 1978) found that SP applied to incubated
hypothalami caused an increase in somatostatin release.
Incubations of pituitary segments with SP inhibits ACTH
secretion (Jones 1978). Intravenous injection of SP
stimulated B-endorphin and B-lipotropin release in rats as
measured in serum, however the source of release was not
clear as B-endorphin is present in other tissues besides the
pituitary. In vitro studies showed that SP induced B-
endorphin release from dispersed anterior pituitary cells in
a dose related manner (Matsumura 1982) suggesting that SP is
acting directly at the level of the anterior pituitary.
The effects of SP on luteinizing hormone (LH) are of
particular interest since SP levels in the AP are regulated
by gonadal steroid hormones, yet these studies have not
conclusively shown the site of action and appear to be
dependent on the route of administration. For example,
intravenous injection of SP resulted in reduced plasma
gonadotropin levels in ovariectomized female rats, while
intracerebroventricular injection of SP resulted in an
increase in LH levels (Vijayan 1979). In the same report
pituitaries incubated with SP in vitro resulted in no change
in LH release. These data suggest that the effects of SP
observed in vivo were mediated via gonadotropin releasing
hormone.
Other in vitro studies have shown conflicting results,
for example, a stimulatory effect of SP on LH release has
been reported by Fisher (1974) using in vitro pituitary
incubations from 20 day old female rats. In contrast, SP
significantly inhibited the ability of gonadotropin releasing
hormone (GnRH) to stimulate release of LH from primary
anterior pituitary cell cultures prepared from rats in
diestrus I and proestrus, but not at diestrus II or estrus
(Kerdelhue 1978).
Intracerebroventricular administration of SP antiserum
increases LH secretion before and after the surge with no
effect on the magnitude of the LH surge itself, implying that
SP may be inhibiting LH secretion at selective times during
the cycle. The location of the effect can not be determined
from this experiment, however.
In another report (Dees 1985) lateral ventricular
injection of an antiserum to SP resulted in significantly
suppressed LH levels in castrated male rats, suggesting that
SP may have a stimulatory action. An antiserum to SP
administered intravenously reduced LH secretion within 24
hours in male rats treated with estradiol whereas this effect
was not seen in intact male rats of comparable size. This
finding suggests that SP may stimulate LH secretion, although
it is not possible to determine at what site the antiserum is
blocking SP action. This study also suggests that the LH
stimulating effect of SP depends on the hormonal status of
the animal. Alternatively, estradiol could be acting to alter
the clearance rate of the antiserum thereby prolonging the
effect.
What emerges then, from these studies is that SP shows
effects that may be different depending on the site of action
and also on the hormonal state of the animal. To date it has
not been possible to define with precision the role SP plays
in the control of anterior pituitary hormone secretion. It is
difficult to interpret studies in which SP is administered
peripherally because peptides of similar molecular weight
have been shown to cross the blood brain barrier only to a
limited extent leaving questions about the site of action
unanswered.
Intracerebroventricular injections of microgram
quantities of SP may result in nonphysiological effects on
hypothalamic or other brain regions which may receive
neuronal SP input or regions which do not normally have
access to SP.
Studies using SP antisera are problematical because of
confusion as to where these large proteins are diffusing to
and acting. The antisera may not be specific for SP or may be
contaminated with large enough amounts of the peptide to
cause an effect. Further, antisera to SP may not necessarily
block SP action but could act in an opposite way by
stimulating the aggregation of receptors. Anti-insulin
antibodies enhance the biological activity of submaximal
doses of insulin by stimulating the clustering of insulin
receptors (Kahn 1978).
While intriguing these studies raise many questions. Are
the effects of SP strictly pharmacologic? Where does SP act,
directly on the anterior pituitary or indirectly at the
hypothalamic level or both? Why does hormonal status
influence SP concentration in the anterior pituitary gland
but not in the hypothalamus and does hormonal status
influence SP actions?
Other Peptides Implicated Anterior Pituitary
Regulation
Secretion of AP hormones is controlled by a complicated
interplay of neural factors and negative and positive
feedback signals from the target endocrine glands. More
recently, it has been shown that in addition to the classical
hypothalamic releasing factors or primary stimulators of AP
hormone secretion, other peptides including neuropeptide Y
(Kalra et al 1983; Crowley and Kalra 1987), neurotensin
(Vijayan et al 1988), angiotensin II (Steele et al 1985),
opiate agonists (Blank et al 1986; Cicero et al 1986), and
vasoactive intestinal peptide (Abe et al 1989) affect the
release of AP hormones. Many of these peptides are present in
the hypothalamus and there is evidence that some may affect
the release of hypothalamic releasing factors or may be
released into median eminence blood vessels (Kalra 1983;
Crowley 1987). In addition these peptides may be synthesized
and stored within the pituitary and released to act in a
paracrine or autocrine way (Abe et al 1985; Nagy et al 1988).
Several peptides in addition to gonadotropin releasing
hormone (GnRH) affect gonadotropin release and may act as
secondary modulators (Kow et al 1988; Crowley et al 1987;
Chabot et al 1988; Blank et al 1986). Neuropeptide Y (NPY) ,
a 36 amino acid peptide isolated from bovine brain, is one
such peptide prominent in the literature. Depending on the
gonadal hormone milieu, intracerebroventricular injection of
NPY has been reported to inhibit (Kerkerian et al 1985) and
stimulate (Kalra et al 1984) LH release. It is thought that
the actions of NPY may have physiological significance
because of findings that NPY concentrations in certain
hypothalamic regions are regulated by ovarian steroids and
because the peptide stimulates the release of GnRH from
medial basal hypothalamus (Crowley et al 1985; Crowley et al
1987) .
Evidence suggests that NPY may be a unique modulator of
LH secretion in that it promotes GnRH release and may be
secreted into the portal blood to enhance GnRH stimulated LH
release. NPY-like immunoreactivity has been demonstrated in
corticotrophs, lactotrophs, somatotrophs and gonadotrophs
(Chabot et al 1988). These researchers have shown a direct
effect of NPY (l~M) on the pituitary to stimulate LH. Perhaps
it will be found that other peptides play important roles at
both CNS and AP levels in the complex neuroendocrine
communication which must be required for fine tuning of
anterior pituitary hormone secretion.
Another peptide which plays an important role in
pituitary regulaton is vasoactive intestinal peptide (VIP).
VIP has been detected in lactotrophs (Morel et al 1982) and
causes release of PRL in vivo and in vitro (Frawley and Neill
1981; Samson et al 1980). VIP content in the anterior
pituitary is increased in hypothyroidism, an effect which was
reversed by T4 replacement (Lam et al 1989). In this aspect
the regulation of VIP content resembles that of SP in the
anterior pituitary.
Rationale and Objectives
The discovery of SP in hypothalamus and anterior
pituitary, and the finding that SP concentrations in anterior
pituitary are regulated by the hormonal status of the animal
generated the idea that there may be a specific functional
significance of this peptide in the anterior pituitary.
Several types of experiments suggest that SP can affect AP
hormone secretion; however, striking differences in the
effects of SP have been reported depending on the
experimental protocol and the method of administration. This
has resulted in a confusing literature with the question of
whether SP acts at the level of the anterior pituitary to
regulate AP hormone secretion still unanswered.
The sex differences in APSP concentrations and the
regulation of those concentrations by gonadal steroids are
supportive of the notion that SP may play a role in
regulating gonadotropin secretion. The experiments which
address the question of the effect of SP on LH secretion are
particularly confusing. Al though significant regulatory
control of LH secretion takes place in the central nervous
system, mechanisms within the anterior pituitary allowing for
local control cannot be ruled out. For these reasons I
decided to focus on the effect of SP on LH secretion. In this
thesis I propose the hypothesis that SP may play a functional
role in the regulation of LH secretion by an action within
the anterior pituitary.
Approach
Evidence that SP mediates a particular biological effect
is usually based on the following lines of evidence: 1 )
presence, immunohistochemistry shows immunoreactive SP at the
appropriate location, release, SP can be released by the
appropriate tissue, 3) efficacy, exogenous SP elicits the
effect, 4) demonstration of receptors, binding and/or
autoradiographic studies show SP receptors at the appropriate
target site (Maggio 1988).
The presence of SP and its biosynthesis in the anterior
pituitary gland has been established (Morel 1982; DePalatis
1982; Aronin 1984; Jonassen 1987). The release of SP from
hemipituitaries in a K+-stimulated, Ca++-dependent manner has
been established (Aronin 1984), however, a physiological
stimulus for release or the possibility of release of SP in
vivo has not been established. The ability of SP to modulate
LH release by acting directly on the anterior pituitary was
evaluated using short term primary cultures of anterior
pituitary cells with the goal of satisfying the third of the
above criteria. In order to satisfy the fourth criteria and
to correlate the sex and age differences in the SP
biological effect to differences in SP receptor affinity or
number, SP binding was studied in anterior pituitary membrane
preparations. To examine the possibility that SP may be
released from anterior pituitary cells to act directly on its
own or surrounding cells experiments were done using SP
antibody to alter endogenous SP effects.
Choice of Assay
The use of cell cultures of pituitaries for studying
pituitary hormone secretion provides a number of advantages
over in vivo experimentation or in vitro systems using
hemipituitaries. Primary cultures of pituitary cells allow
the complete isolation of the pituitary from neural and
humoral influences and the addition of test substances under
a controlled environment. The reproducibility of LH release
is much higher in cell cultures than in hemipituitaries
because cell cultures are prepared from several animals and
individual differences tend to be damped out. Problems with
uniform dispersion of test substances, oxygen and C02 are
difficult to overcome in incubations of hemipituitaries.
There are also disadvantages to use of primary culture
systems for physiological studies. First, it is not a
physiological model to be compared with an in vivo model. The
isolation of the tissue from neural and humoral influences
could result in artifactual results which do not reflect the
in vivo response. Also the preparation of cells is
heterogeneous introducing questions about what cell type may
be affected by a test substance. There have been no reports
of a continuous culture line that releases gonadotropins in
response to GnRH which would provide a more homogeneous
system for the study of receptor and signal transduction
mechanisms. Separation of pituitary gonadotrophs on the basis
of their larger size has been achieved with moderate success,
however this process requires extremely large numbers of
animals to get a reasonable yield for experimentation.
In contrast, preparation of primary cultures is a
relatively simple procedure. Anterior pituitaries are removed
and treated with enzymes (collagenase and hyaluronidase)
order to break down intracellular connections, subjected to
mechanical disruption and placed in suitable culture dishes
in growth medium. Independent tests of cell viability, such
as stimulation of hormone release, maintenance of normal cell
function and morphology and trypan blue exclusion can then be
performed. Cells which have been in culture for between 18
hours and 4 days possess excellent responsiveness to GnRH in
releasing LH and to TRH in releasing TSH (Nakano et aI, 1976) .
Studies have shown that 1-3 day pituitary cell cultures
maintain many of the characteristics of the animal from which
they were prepared and pituitary cells from different animal
models behave differently in both a physical and
physiological sense. Denef et al (1978) found differences in
the gravity sedimentation rate of gonadotrophs from 14 day
old males, 14 day old females, and adult males and also found
that each of these models responded to GnRH differently. Tang
and Tang (1979) have reported that GnRH stimulation in
cultured pituitary cells from adult females induced larger LH
responses than in cell cultures from adult males. The authors
interpret this result to indicate differences in gonadotroph
population.
It has also found that pituitary cells from adult female
rats released more LH than did pituitary cells from adult
male rats (Nakano 1976). Snyder et al (1976) found that basal
PRL secretion differed in cells from normal and castrated
adult female rats indicating that the effects of gonadal
steroids on PRL secretion remain after cells are placed in
culture. It is well known from in vivo studies that changes
in the responsiveness of the pituitary to GnRH occur
throughout the female reproductive cycle (Arimura 1977). In
18 hour pituitary cell cultures taken from adult female rats
at different stages of the estrous cycle LH responses to GnRH
were significantly greater in cells taken from diestrus-II
and proestrus animals compared with those from estrus or
diestrus-I (Baldwin 1981). O' Connor et al (1980), in a study
using 3 day cultures of pituitary cells derived from intact
and ovariectomized females, found that ovariectomy increased
the GnRH induced LH release by more than 2-fold. However,
Reel et al (1978) reported that female rat anterior pituitary
cells, taken from rats at different stages of the estrous
cycle, lose the characteristic responsiveness to GnRH when
placed in culture for 1-4 days.
Because cultured cells provide a simple and direct way
of assessing regulation of hormone secretion in anterior
pituitary and maintain physiological differences between male
and female, I decided to use the short term primary culture
model system for defining the role of SP in the anterior
pituitary. Using the information from the above reports and a
report by Hopkins (1977) , which states that a 48 H recovery
period is needed after dispersion in order to regain response
capability, the secretion experiments in this project were
designed to use 48-72 H cultures of AP cells.
In the attempt to further characterize the responses of
anterior pituitary cells to SP, radioligand binding studies
of SP binding sites in the anterior pituitary were done to
examine possible alterations in SP binding parameters
(changes in number or affinity of the receptors) in the
anterior pituitary. This binding assay protocol (described in
Materials and Methods) is almost identical to the method used
in characterizing the GnRH receptor and many other anterior
pituitary receptors (Clayton 1981) 
Specific and saturable high affinity binding sites for
SP have been demonstrated in the anterior pituitary using
different ligands: 3H- SP or the analog 12SI-D-TyrO-NorLeu11-SP
(Kerdelhue et aI, 1985). In this study the Kd is between 1.
and 20 nM, similar to that reported for brain cortex and
parotid cells. Further there is a similar index of
specificity for binding of SP fragments and analogs. These
authors report that the number of adenohypophyseal SP
receptors was altered during the estrus cycle of the rat,
being highest on the afternoon of proestrus during the LH
surge. More recently, SP binding sites were described in
whole anterior pituitary cells using IBHSP as the ligand
(Larsen 1989). They report a Kd of 0. 48nM with a Bmax of 1187
sites/cell and demonstrate that SP is internalized and
degraded after binding to a cell surface receptor. These
results imply that SP effects at the level of the anterior
pituitary are mediated via specific receptors on the cell
surface.
Sumary Goals
The goal of the present studies was to clarify the
effects of SP on the secretion of LH, to characterize the
binding of radiolabeled SP to AP membranes and to explore the
possibility of regulation of the response and binding
parameters by the hormonal status of the animal.
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MATERIALS METHODS
Materials
Substance P and analogs of SP were purchased from
Bachem Inc . Selective SP receptor agonists were a gift from
Dr Domenico Regoli. GnRH was purchased from Sigma Chemicals
or Boehringer Mannheim Biochemicals. Collagenase was
purchased from Cooper Biomedical. Hyaluronidase and DNase
were purchased from Sigma Chemicals. Dulbecco ' s Modified
Eagles Medium with glucose and L-glutamine without phenol
red, horse serum, fetal calf serum, gentamycin sulfate and
non-essential amino acids were purchased from Sigma
Chemicals. LH radioimmunoassay materials were donated by the
National Institute of Diabetes, Digestive & Kidney Diseases
(NIDDK) through the National Hormone and Pituitary Program
at the University of Maryland School of Medicine. SP
Radioimmunoassay materials were provided by Dr. Susan Leeman.
Goat anti-rabbit IgG for use as a second antibody in the LH
RIA was purchased from Antibodies Inc.
Chemicals used in homogenization, binding and
physiological buffers such as Tris, Hepes, dithiothreitol,
BSA, EDTA, sodium, magnesium and calcium chloride, sodium and
potassium phosphates etc. were all purchased from Sigma
Chemicals.
Animals
Sprague Dawley rats,purchased from Charles River
Breeding Labs or Harlan Sprague Dawley, of different age and
sex depending on the experiment, were used in all binding and
pituitary culture experiments. In some experiments rats were
made hypothyroid by replacing the drinking water with a
solution of 0. 05% methimazole and glucose for a period of 21
days. Hypothyroidism was verified by TSH RIA initially and
then by SP RIA of anterior pituitary homogenates. The latter
method proved to be a reliable test of hypothyroidism in
rats. Adult female rats were used at random stages of the
estrous cycle. In some experiments, intact female rats were
surgically implanted with silastic tubing of 20mm lengths
which were either packed with androgen (5-a-
dihydrotestosterone, Sigma) or empty for controls. These
implants were left in place for a period of 6 weeks and were
intact at the time of sacrifice of the rats. Androgenization
of females was verified by SP RIA of anterior pituitary
homogenates.
Preparat.ion
Radioligand
of Ant.erior Pit.uit.ary
Binding Assay
Membrane s for
Rats were killed by asphyxiation with CO and then
decapitated. The anterior pituitaries were rapidly removed
and placed in ice cold 25 ro Hepes buffer containing 137 ro
NaCI, 5ro KCl, 0. 7 ro Na2HP04, 0. 36 ro CaCl2 and 10 ro glucose.
The tissue was placed in a glass homogenizer in 30 mls of a
homogenization buffer (pH 7. 4) containing 10 ro Tris-HCl, 
ro DTT, 5 ro EDTA and 0 . 1%BSA and homogenized on ice with 20
passes. The resulting tissue extract was centrifuged at 1000
g for 10 minutes at 4 C. The supernatant was then centrifuged
at 10, 000 g for 20 minutes at 4 C. The resulting pellet was
washed 2 times by the same procedure. The pellet was
resuspended in 1 ml of homogenization buffer with 250 ro
sucrose, frozen in liquid nitrogen and stored at -80 C until
the time of assay. An aliquot of the membrane preparation was
saved for Lowry protein determination.
Preparat.ion Dispersed Ant.erior Pit.uit.ary Cells
Rats were killed by asphyxiation with CO and
decapitated. Anterior pituitaries were removed and placed in
Hepes buffer (described above) warmed to 37 C. This and all
other buffers and media used in preparation of cells for
culture were sterilized by filtration through a 0.
micrometer membrane filter. Pituitaries were rinsed with
buffer and incubated in the above mentioned Hepes buffer
containing collagenase (3 mg/ml) and hyaluronidase (1 mg/ml)
to digest connective tissue holding cells together, DNase
02 mg/ml) to digest any DNA that had been released from
broken or damaged cells, and BSA (3%). The tissue was digested
for 60 to 90 minutes in a shaker bath at 37C. Pituitaries
were then mechanically dispersed in this solution by gentle
trituration with sterile, plastic disposable pipets. The
cells were collected by centrifugation at 70 g for 10
minutes, washed 3 times in Hepes buffer and once in DMEM
culture media. Cells were then either counted using a
hemocytometer and cell viability determined by trypan blue
exclusion (consistently greater than 90%) or directly
aliquoted (. 25- 3 pituitary equivalents/well) into sterile 
well tissue culture plates (Falcon) and incubated in 1ml DMEM
with 10% horse serum, 2. 5% fetal calf serum (both types of
serum were treated with dextran coated charcoal to remove
steroids and thyroid hormones), gentamycin (10mg/ml) and non
essential amino acids (2mM) for 48 hours in a metabolic
incubator at 37 C with 5% C02 and 95% air. One anterior
pituitary from an adult male rat consistently yielded 1.
5x10- cells Preliminary studies using this experimental AP
cell model revealed that cells were viable, attached to wells
in a monolayer with a low basal release of LH and were highly
responsive to GnRH. An incubation period of 4 H was used in
order to achieve the maximal LH response to GnRH and to SP.
Hopkins (1977) and Baldwin (1984) have shown that GnRH
induced LH release biphasic with an initial release within
min. followed by sustained release during the next 90-120
min. Hopkins also reports that cells become refractory to
GnRH after 4 
Radioligand Binding Assay
To examine the binding of SP to AP membranes, we
prepared an iodinated ligand, 
12SIBHSP. This ligand is more
easily synthesized and has a higher specific radioactivity
than 3H-SP. In a comparison study, the specific binding
(disintegrations/min) of 3H-SP (S. A . =27. 6 Ci/mmol, 2. 4x10-
was only 0. 6% that of 12S IBHSP (S. =1500 Ci/mmol, 3. 4x10-
(Cascieri and Liang, 1983). More importantly, 12SIBHSP retains
normal biological activity. One of the drawbacks is that the
Bolton-Hunter group, which is a 3- (3- iodo-4-
hydroxyphenyl)propionyl group attached to what was a free
amino group on the native peptide, results in changes in
charge, size and hydrophobicity creating the possibility that
the radioligand may not have the same binding specificity as
the native peptide. However, this consideration is more
important in experiments on receptors for aliphatic
tachykinins such as SK and neurokinin B, where the Bolton-
Hunter group may yield a peptide with significantly greater
affinity for the receptor than the native peptide (Lee 1986).
125 I-BHSP (S . A. = 2000 Ci/m mole) was iodinated by
conjugation of SP to an iodinated Bolton Hunter reagent (125I-
N-hydroxysuccinimide ester of p-hydroxypropionic acid, NEN)
125 1 labeled Bolton Hunter reagent (2 mCi) was flushed with
nitrogen to evaporate the solvent. SP (5 micrograms in 
microliters borate buffer, pH 8. 5) was added to the tube and
incubated at 0 C for 1 hour and at 4 C for 18 hours. The
active ester acylates terminal or lysine amino groups with
the iodinated p-hydroxyphenylpropionic residue. The iodinated
peptide was purified by HPLC separation using a reverse phase
column (Bondapak C s, Waters). Approximately 150, 000 cpm of
this radioligand was incubated with the membrane preparation
in the presence of increasing concentrations of various
peptides in polypropylene tubes in a final volume of 0. 500 mI.
For binding studies, an aliquot of tissue suspension
equivalent to 0. 250-0. 350 mg protein was incubated in a total
volume of 0. 500 ml of homogenization buffer adjusted to
contain 1 ro 1-10 phenanthroline in the presence of 1251 BHSP
(0. 1-0. 2nM) with or without increasing concentrations of
unlabeled SP for 90 minutes at 4 (Kerdelhue, 1985).
The incubation was terminated after 90 minutes by the
addition of 3 ml of ice cold 10 ro Tris-HCl (pH 7. 4) to each
assay tube. The reaction mixture was immediately filtered
using a Brandel vacuum cell harvester, through glass fiber
filters (GF-C, Whatman) pre-soaked in 0. 01% pOly-ethylimmine
to reduce nonspecific binding to the filter. Tubes and
filters were then washed 4 times with 3 ml ice cold wash
buffer. The entire filtration sequence took 12-15 sec for
each tube. The radioactivity trapped on the filter discs was
measured by gamma counting. Samples were assayed in
triplicate. Under these experimental conditions the amount of
radioactivity retained on the filters in the absence of
membranes was less than 0. 01% of the total radioactivity
added, and this was not displaced by unlabeled SP.
Stimulation Secretion
To determine whether SP had a direct effect on
gonadotropin secretion we exposed anterior pituitary cells
which had been in culture for 48 hours to various doses of
SP. Cultured cells were first washed 3 times with serum free
DMEM after which fresh medium (DMEM without serum) containing
the test substances was applied. After a 4 hour incubation in
a metabolic incubator at 37C in an atmosphere of 5% CO and
95% air, medium was collected, centrifuged at 10000 rpm in a
Beckman micro centrifuge and stored frozen at -20C for
determination of gonadotropin content by LH RIA. Cells were
quickly rinsed in PBS and stored frozen at - 80C for
determination of protein content by Lowry protein assay or LH
RIA.
It became necessary during the course of the experiments
to determine the manner in which the results should be
expressed and how results should be normalized. Table 6
indicates the release of LH from normal adult female rat AP
cultures in response to GnRH and SP on the basis of nanograms
per ml of media (which is the same as ng per culture per 4 
as well as on the basis of hormone released per mg of
protein. It may be seen that the changes in LH release in
response to GnRH and SP remain the same whether results are
compared on the basis of ng per ml or ng per mg protein
therefore the validity of the results expressed as ng per ml
is substantiated. Data from individual experiments were
normalized by presenting the results as a percentage of
control wells (in parallel cultures). This is a widely used
method of normalizing data from pituiary cell culture
secretion experiments. In individual experiments the standard
errors of treatment replicates was consistently less than
10%, however interassay variability was greater than within
assay variation. To minimize the effect of biological
variation and variability between experiments, large numbers
of animals were used and experiments were repeated several
time s .
Radioimmunoassay
LH concentration in media was measured by using an RIA
kit supplied by the NIADDK containing rat luteinizing hormone
reference preparation RP-3 as a standard and rat luteinizing
hormone antiserum from rabbit. ILH was purchased from NEN
Research Products. All reagents were added to 12x75
polystyrene RIA tubes in the sequence 1) buffer (PBS +
o . 1%BSA), 2) cold standard or unknown, 3) antiserum diluted to
a final tube dilution of 1: 180000, 4) radio iodinated 
(NEN). The reagents were then incubated at room temperature
for 24 hours followed by the addition of second antibody
(goat anti-rabbit IgG), which facilitated separation of bound
LH from free LH, and another 24 hour incubation at room
temperature. Intra and inter assay variation was less than
10%. Three to six wells were used for each treatment in all
experiments, and all samples from the same experiment were
assayed in duplicate in the same assay. Results of LH assays
were expressed as ng/ml/well/4 h. Data from individual
experiments were normalized by presenting the results as net
increases in LH secretion or as a percentage of basal LH
release in parallel cultures. Protein determinations of
homogenized AP cells from random wells was done in each
experiment, using the method of Lowry (1951), to assure equal
distribution of cells.
Incubation of AP cells with antibody
An anti-SP antiserum (SPAb) was a gift from Dr. Susan
Leeman. In crossreactivity studies the antibody had no
crossreactivity with neurotensin or TRH, and less than 0. 05%
with SK. Preliminary studies to assess the ability of this
antibody to inhibit SP-induced LH release using non immune
rabbit serum as a control indicated nonspecific inhibition of
LH release by the non immune serum (NRS) as well as the anti-
SP serum. It was not clear whether this was due to a
crossreaction in the LH RIA or an action on the cultured
cells to inhibit LH release. Thus a partial purification of
the antibody was undertaken wherein an ammonium sulfate
precipitation was done on both sera. The resulting
precipitate was dissolved in water and dialyzed to remove
ammonium sulfate. The purified SPAb and NRS at concentrations
used in the cell incubations (1: 100 dil of sera) did not
crossreact in the LH RIA.
Statistics
The Student' s unpaired t test was used to test for
significant differences between two means. When more than two
means were being statistically compared, one-way or two-way
analysis of variance was performed, followed by Duncan s new
multiple range test and/or Scheffe ' s F-test of multiple
comparisons. Values in the text are expressed as the mean +/-
SEM.
Table , LH released from pituitary cell cultures
LH Released
Treatment ng/ml media ng/mg prot
Control
GnRH (10nM)
SP (100nM)
GnRH (10nM)+SP (100nM)
146.3 :t 52
5591 :t 771
2713 :t 385
5936 :t 884
6 :t .
62. 1 :t 8.
30. 1 :t 4.
64.8 :t 9.
Cells were obtained from the anterior pituitary glands of 30-35 day old normal male
rats. After dispersion and 48 hours of culture cells were rinsed and incubated for 4 hours in
1 ml media with or without treatment. Media was collected and assayed for LH by RIA. Results
are expressed as both nanograms of hormone per ml of media and nanograms of hormone per mg
of protein :t SEM of six replicates.
III RESULTS
Experiment #1- Anterior Pituitary Stimulation of LHCells in Culture Secretion from
In order to determine whether SP can affect LH secretion
from AP hormone secretion by acting directly at the level of
the AP gland, we examined the effects of exogenous SP on LH
secretion from anterior pituitary cells in culture.
Since the AP cell culture system used in these studies
had not been previously established in our laboratory, the
purpose of the first set of experiments was to confirm that
the AP cells in culture were viable and responsive to GnRH in
a dose dependent manner and to determine the maximally
effective dose for subsequent experiments. In preliminary
experiments (data not shown) GnRH at 10-9 to 10-
significantly enhanced LH release into the media in a dose
dependent manner with a maximal response obtained at 10-
GnRH after 4 hours of incubation. This is in agreement with
reports in the literature of GnRH dose and incubation time
for maximum response.
Previous sudies have demonstrated that prepubertal rats
of both sexes have the same concentration of APSP. The
concentration of APSP in male rats increases from the onset
of puberty until adulthood when males have 2-3 fold more APSP
than females. Since rats of different age and sex have
different SP concentrations in the AP, it was reasoned that
AP cells in culture prepared from rats of different age and
sex may respond differently to SP. AP glands from adult and
juvenile (30 days) male and female rats were dispersed into
single cells and kept in culture for 48 hours prior to
incubation in 100nM SP, 10nM GnRH and both of these
substances together. These were doses of GnRH and SP that
Kerdelhue (1978) reported which suggested that SP may inhibit
GnRH stimulated LH release in 7 day cultures of AP cells from
proestrus rats.
Figure 1 shows the pooled results of 4-6 experiments for
each age group and sex. In each experiment we compared the
GnRH stimulated LH release from treated wells to that seen in
untreated control wells and results were expressed as % of
control wells. In contrast to the findings reported by
Kerdelhue, we found that SP failed to inhibit GnRH stimulated
LH release from AP cells derived from either male or randomly
cycling female rats. Rather there was a small albeit
statistically insignificant increase in LH secretion in the
presence of SP that could be seen in cells from adult female
and to a lesser extent from juvenile male anterior
pituitaries. Given these findings we examined the effects of
SP on LH release from adult female AP cells in more detail.
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FIGURE 1. LH secretion in response to
GnRH and SP in AP cells in culture. 
hour cultures of AP cells from adult and
juvenile male and female rats were incubated
for 4 hours in the presence of SP and/or GnRH
at the indicated concentrations. Error bars
represent standard errors of the mean LH
values from 4- 6 experiments.
Experiment #2-Sex Difference
Release by SF in Cultured AP
in theCells Stimulation offrom Adult Rats
Anterior pituitaries of adult female rats (175-200 g)
were dispersed to single cells and placed in culture for 48
hours prior to incubation in 100nM SP. Separate wells
contained 10nM GnRH to assess cell viability and
responsiveness. A total of 8 separate experiments were
carried out. As a comparison, Figure 2 also shows results of
7 separate experiments in which cultured AP cells from adult
male rats were stimulated with 100nM SP. In the preliminary
experimets shown in Figure 1 standard errors were so large
that significant diffeences could not be seen in the female
AP cells. In this experiment attempts were made to
standardize the assay and fewer cells were aliquoted into
each well (approx. 1/4 AP /well) . Individual Student' s t
tests were performed comparing stimulated to control values.
As shown in Figure 2, SP at a concentration of 100nM
significantly stimulated LH release . 01) from 48 hour
cultures of anterior pituitary cells from female rats but had
no effect on LH release from male anterior pituitary cells.
In these studies GnRH at a concentration of 10nM was
effective in stimulating LH release from female (1526+/-377%)
and male (1134+/-363%) cells and was used at this
concentration in all subsequent experiments to stimulate LH
secretion as a measure of cell viability and responsiveness.
Basal or control values, (defined as ng. of LH secreted into
the media in parallel wells that did not have SP or GnRH
added) were 380+/-41 ng/ml media for the female AP cells and
477+/-178 ng/ml media for male AP cells.
The absence of LH release in response to 100nM SP in the
AP cells from male rats could suggest a lack of, or fewer SP
receptors on AP cells, presumably gonadotrophs, in the male
rat. Gonadotrophs represent approximately 14% of anterior
pituitary cells in both males and females, however there is a
sex difference in the percentage of multihormonal (LH/FSH)
cells in the rat (Tougard 1988). Multihormonal cells account
for 37-40% of gonadotrophs in the female as compared with 70%
in the male. Perhaps it is the monohormonal cell which
responds to SP. Follicle stimulating hormone (FSH) was not
assayed in this experiment, but could be in future
experiments to determine whether there is a sex difference in
FSH release. Cicero (1986) reported a sex difference in LH
content in APs of adult rats. Females have time s less
content than comparably aged males. One might expect then
that the female rat there less LH to be released.
content of cultured AP cells used in this experiment were the
same in males and females (approx. 26+/-8 ~g/well) .
SEX DIFFECE IN THE STIMUTION OF La RELEE
BY SP IN CULTUD AP CELLS FROM ADULT RATS
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FIGURE 2. Sex difference in the
stimulation of LH release by SF in
cultured AF cells from adult rats. 
hour cultures of AP cells from adult male and
female rats were incubated for 4 hours in the
presence or absence of a final dilution of100
nM SP in culture media. Error bars represent
the standard error of the mean of 7 (male) and
(female) separate experiments. Basal values
are 380+/-41 (female AP cells) and 477+/-178
(male AP cells). (* . 01 versus control
values) .
Experiment#3-Dose ResponseStimulated LH Release Relationship
The dose reponse relationships for the SP stimulation of
LH release was measured in anterior pituitary cell cultures
from adult male and female rats. As shown in Figure 3A in AP
cells from adult females SP stimulated LH release in a dose
dependent manner. In contrast, cells obtained from adult male
rats were less responsive to SP at doses higher than 100 nM
SP and remained significantly lower up to 1. 0 ~M SP. Cultured
AP cells from adult males do begin to respond at a dose of 
~M SP, whether this is a physiological or more a
pharmacological response is not known. Later results in this
thesis show that 1 ~M SP can displace 1251 GnRH from anterior
pituitary membranes, suggesting that SP at high doses may
cross react at the GnRH receptor. Statistical analysis was
done using factorial ANOVA followed by Scheffe ' s F-test.
Preliminary experiments indicated that peripubertal male
rats also responded to SP, so it was decided to examine the
dose response relationship in 30-35 day old male rats. Figure
3B shows that AP cells from peripubertal male rats were
highly responsive to SP. Statistical analysis was done using
ANOVA followed by Duncan s new multiple range test.
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FIGURE 3. SP dose response in cultured AP
cells from adult male and female rats.
Parallel wells were incubated with the indicated
concentrations of SP for 4 hours. In wells
incubated with 10nM GnRH LH values were 1438+/-394%
of control in cells from female and 1330+/-546% of
control in the cells from male. At doses over 100nM
SP there is a significant stimulation of LH release
into the media OOl versus control values) in AP
cells from female rats. Error bars represent the
standard error of the mean of LH values from 4
(male) and 6 (female) separate experiments. At l
SP, LH release from AP cells of male rats is
significantly . 05) different from control
values. At values of 1 SP, however, stimulation
of LH release from cells of female rats is
significantly greater . 001) than LH release from
cells of male rats. Basal values are 350+/-27
(female AP cells) and 287+/-89 (male AP cells). 
Ol, OOl) .
FIGURE B. SP DOSE RESPONSE RELATIONSHIP IN THE
STIMULATION OF LH RELEASE IN CULTURED AP CELLS FROMJUENILE MALE RATS
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Experiment#4-Effect of Age on the Sex Differencein theStimulation of LH Release by SP from Cultured AP Cells
The previous experiments established that AP cell
cultures from female rats released more LH than AP cells
prepared from adult male rats. Yet AP cells prepared from
younger male rats were highly responsive to SP (Fig. 3A +
3B). These results introduced the idea that there may be
differences in the response depending on the age of animals
of a given sex. In order to determine the effect of age on SP
stimulated LH release, cultured anterior pituitary cells from
male and female rats of different ages were incubated for 
hours with 100nM SP. Figure 4 shows that in both males and
females between the ages of 28 and 35 days there is a sharp
rise in SP stimulated LH release. This response remains high
in cells from female rats throughout the ages studied,
whereas in cells from male rats the response diminishes to
prepubertal levels by 60 days of age. Although the AP cells
of young male rats are highly responsive to SP , there is a
small window of time of responsiveness, and even at the time
of maximum responsiveness (35 days) there is a wide
variability between results fromseparate experiments as
reflected by the large standard error. For these reasons,
unless otherwise specified, adult female rats (150-200g) were
used to prepare AP cell cultures to further characterize the
response to SP.
It is interesting to note that the increases in
responsiveness to SP noted in the AP cultures from 30-40 day
male and female rats correlate with the changes in LH
regulation that occur at the onset of puberty in the rat.
According to the classification of Ojeda et al (1980)
postnatal development in the rat can be divided into four
phases: the neonatal period, which extends from birth to the
end of the first week of life; the infantile period, which
extends from day 8 to day 21; a juvenile or prepubertal
period, which ends around day 30; and a peripubertal period,
starting at 30-32 days and terminating at the end of puberty
with first ovulation (35-45 days) in the female and with
sperm release from the germinal epithelium (40-45 days) in
the male rat. In the male the maximum LH response to GnRH
occurs between 35 and 45 days of age (Ojeda 1988). Whether
this similarity between SP and GnRH in regard to age of
maximum response is simply correlational or functionally
related is a question of interest.
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FIGURE 4. Development of the LH release response
to SP. 48 hour cultures of AP cells from male and
female rats of the indicated ages were incubated with
100nM SP for 4 hours and LH released into the media was
measured. Error bars represent the standard error of the
mean of 3-6 separate experiments at each age. After 50
days of age there is a significant . 01) difference
bet ween LH release in AP cells from male and female
rats.
Exper iment # 5 - Character i z ation the Specificity
Stimulate Release of LH from AP Cells in Culture
In order to determine the specificity of SP and the
potency of active analogs of SP to cause LH release from
cultured AP cells, adult female rats were exposed to l~M SP
and 1 ~M doses of analogs of SP. The analogs that were tested
included NK1, NK2, and NK3, selective agonists for neurokinin
receptors. The synthet ic analog NK1 (( Sar9 , Met (02) 11) SP) has
been shown to be selective for SP binding sites in both
receptor and bioassays (Regoli 1988). The other chosen
analogs were subtance K (SK) and neurokinin B (NKB) the other
two mammalian tachykinins, which are known to crossreact at
SP receptors, to provide information on the specificity of SP
as opposed to the other tachykinins. We also assessed the
effects of SP free acid (SPFA), a non-amidated form of SP
with a free carboxyl terminus, and SP (1-9) an amino terminal
fragment of SP, to provide information on the section of the
peptide that is important in eliciting LH release. Finally we
examined the efficacy of an unrelated peptide, neurotensin.
Figure 5 shows that SP is most potent after GnRH, in
stimulating LH release but that SK, SPFA and SP (1-9) also
significantly stimulate LH release. Neurotensin neurokinin B
and the selective agonists for the SK receptor (NK2) and the
NKB receptor (NK3) were not effective in stimulating LH
release in these cells.
The NK1 selective agonist has been tested in bioassays
in dog carotid artery for bioactivity and is reported to be
potent and selective with a high affinity for the NK1
receptor. The fact that it is a much weaker agonist than SP
in this system would argue that SP may be acting on a new
type of tachykinin receptor in the anterior pituitary.
Alternatively the NK1 selective agonist may not be as
effective in this system because of the chemical
modifications at amino acids 9 and 11. The activity of SK to
cause LH release and the inability of the NK2 selective
agonist (selective for SK receptor) to cause LH release
suggests that SK may be crossreacting at the SP binding site.
SPFA and SP (1-9) are both analogues of SP which have intact N-
terminal regions. The ability of these compounds to stimulate
LH release implies that it is the N-terminal portion of the
SP molecule which. is important in causing the response. The
fact that NKB and NT do not have any activity shows that SP
does have some specificity in causing LH release.
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FIGUR 5. Stimulation of LH release from
AP cells by SP and other peptides. AP
cell cultures from adult female rats were
incubated in test substances at final
concentrations of 1 . Separate wells were
incubated with 10nM GnRH as a comparison. SP
stimulates LH release significantly (** OOl)
as do NK1, SK, SPFA and SP (1-9) (* 05).
Experiment#6-Stimulation of LH Release by
Cultured AP Cells from Hypothyroid Female
SP in
Rats.
Since hypothyroidism leads to increased SP
concentrations in the anterior pituitary gland of female rats
the question was asked whether raising the level of SP in the
anterior pituitary of the female rat by hormonal manipulation
would act to attenuate the LH release in response to SP
administration. Adult female rats were made hypothyroid by
the addition of methimizole to the drinking water for 21
days. In this experiment SP content was measured by RIA in
anterior pituitaries from normal and hypothyroid females as a
measure of the hypothyroid response pertaining to SP in the
anterior pituitary. The values for SP levels in hypothyroid
females approach normal male values. The mean SP value for
normal female anterior pituitary glands was 89. 5+/-29 fmol
SP/gland (n=4) and for hypothyroid female glands 488+/-96
fmol SP/gland (n=4), whereas values for the intact adult male
are approximately 600 fmol SP /gland. As shown in figure 6 the
response to SP at doses over 100 nM was attenuated
significantly in cultured AP cells from the hypothyroid
female rats. Statistical analysis was done by factorial ANOVA
followed by Duncan s new multiple range test.
However, the LH response to GnRH was also blunted in AP
cells from hypothyroid female rats. Although this decrease in
GnRH stimulated LH was not significant. There are many other
changes that take place in the anterior pituitary in
hypothyroid animals compicating the interpretation of these
studies. LH content measured in the cells collected after
these experiments shows a decrease in LH content in the
hypothyroid cells. AP cells from untreated female rats
contained 22. 4+/-1. 1 ~g/well wheras AP cells prepared from
hypothyroid rats contained 10. 8+/- . 35 ~g/well. It has been
shown that in adult rats thyroidectomy facilitates LH release
and leads to a reduction in LH content in the AP , an effect
which is reversed by treatment with T3 or T4 (LaRochelle
1974). Therefore it is not possible to conclude from this
experiment whether there is a specific change in
responsiveness to SP or whether the reduction in the response
to SP is secondary to other changes produced by
hypothyroidism in the mechanism regulating LH release.
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FIGURE 6. Stimulation of LR release by SP in
cultured AP cells from hypothyroid female rats.
AP cell cultures from normal and hypothyroid rats were
incubated in increasing concentrations of SP. At SP
doses above 100nM there is a significant difference in
LH release into the media in response to SP between
normal and hypothyroid cells (* . 05). LH appears to be
blunted in the hypothyroid cells in separate wells
incubated in lOnM GnRH, this is not a significant
effect.
Expe riment# 7 -GonadalVitro steroid Treatment Vivo and
In order to shed further light on whether the sex
difference in the response to SP is mediated by gonadal
steroids, AP cells were prepared from intact female rats
which had been treated with DHT. In vivo studies indicate
that both estrogens and androgens can alter SP concentrations
in the rat AP. In particular androgen increases whereas
estrogen decreases APSP in female rats (Coslovsky 1984). In
vivo stimulation of APSP content by testosterone was less
than that by DHT, suggesting that aromatization of
testosterone to estrogens could complicate the interpretation
, "
of data. While the AP does not contain the aromatizing
enzyme, in vivo administration of androgen, which may be
aromatized in other tissues, could act on the AP. Therefore,
for in vivo experiments, the non aromatizable metabolite of
testosterone, DHT was used in order to be sure that the
effects measured were due to androgen and not estrogen.
Androgen was administered by surgically implanting
silastic tubing of 20mm lengths which had been filled with
dry crystalline DHT under the skin of the back. Implants were
left in the animal for 6 weeks. This method of administration
of steroids has been shown to result in a sustained release
(approximately 40 ~g/24 hours), which is more biologically
effective than the conventional once a day subcutaneous
injection (Kincl 1970).
As illustrated in figure 7 AP cells prepared from DHT
implanted female rats were less responsive to incubation with
100nM SP in 4 separate observations, although at higher doses
(500nm and l~M SP) there was no difference in LH released
between rats with empty implants and DHT implants (data not
shown). A Student' s t test was done to compare LH release in
treated (DHT implanted) and untreated (control implanted) 
This result would suggest that androgens affect the
sensitivity of the responsiveness of the AP to SP but doesn '
completely cause a conversion of the female response pattern
to the male pattern.
Gonadal steroids have also been shown to modify the AP by
acting directly on the gland (Kingsley 1973). For this
reason it was thought that incubation of cultured AP cells
with gonadal steroids would be a direct and simple way to
explore whether gonadal steroids administered directly to the
AP can alter the stimulation of LH release in response to SP.
The question of whether the response to SP could be
diminished in peripubertal males by exposure to androgens was
approached in this way. For these experiments cultured AP
cells from juvenile male rats of different ages were exposed
to 100 nM DHT or testosterone diluted in 100% EtOH (final
dilution of EtOH in each well was 0. 001% and in preliminary
experiments had no discernable effect on cells) for 48 hours
prior to incubation with SP. It has been shown (Drouin 1976)
in AP cells from adult female rats, that 48 hours of exposure
to DHT or testosterone inhibits the LH response to GnRH.
Table 7 shows results from the experiment in which AP
cells from peripubertal male rats were exposed to DHT,
testosterone or EtOH vehicle alone. These values from 3
separate experiments are expressed as ng LH/ml media because
of the increase in basal LH secretion after exposure of cells
to DHT or testosterone. Basal release is increased compared
to control (EtOH vehicle) in AP cells treated with DHT or
testosterone. The reason for this is unknown. In adult rats
androgens have the opposite effect, LH secretion in response
to GnRH is reduced in response to androgen exposure, with no
effect on basal release. However, there is evidence that the
sensitivity of the hypothalamic pituitary unit to the
negative feedback effect of androgens declines during sexual
development and that this change, which is especially
noticable at puberty, may be responsible for maintenance of
LH release in the face of rising testosterone levels and may
play a role in the induction of puberty (Negro-Vilar 1973) .
This decreased sensitivity to the negative feedback action of
androgens may be in evidence in the androgen exposed AP cells
from peripubertal male rats. It could be termed a positive
feedback action of androgens in that basal levels are
increased. The reduced effect of SP and GnRH to stimulate LH
release above basal, is perplexing and may be evidence of a
maximal stimulation of LH release.
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FIGURE 7. SP Stimul.ation of LH Rel.ease fromA
Cel.ls of DHT Impl.anted Rats. AP cell cultures
prepared from androgenized rats were exposed to SP
for 4 hours. LH released into the media was
measured. For controls AP cells were prepared from
rats implanted with empty capsules. Basal values
for LH were 457+/-92 ( control AP cells) and 375+/-36 (DHT AP cells). (*p.c. 05)
TABLE-7 LH SECRETION IN. AP CELLS PREPARED FROM 30-35 MALE
RATS- EFFECT OF ANDROGEN TREATMENT OF CELLS
TREATMENT LH IN MED 
(NG/ML MEDIA)
ETOH DHT
CONTROL
SP (100NM)
SP (l~M)
GNRH (1 ONM)
1061+/-178
3443+/-1137
4564+/-1385
5570+/-2042
4096+/-1150
3826+/-1195
4425+/-1215
4890+/-591
4048+/-1244
3754+/-784
4432+/-1531
6624+/-2356
Values are given in ng LH/ml media and represent mean+/- SEM
of 3 observations.
ETOH=EtOH vehicle, DHT=dihydrotestosterone, T=testosterone.
Experiment#8-Substance P Antibody
Release in Cultured AP Cells Inhibition
SP is synthesized and its concentrations are regulated
hormonally within the anterior pituitary. SP is releasable
from hemipituitaries in a Ca++ dependent-K+ stimulated manner
(Aronin 1984). These observations support the view that SP
may be released in response to an unknown physiological
stimulus to act on its own or on neighboring cells in a
paracrine or autocrine way. In order to explore this
possibility cultured AP cells from female rats were incubated
for 4 hours in the presence of SP Ab to inhibit any action of
endogenous SP on LH release into the media. SPAb and normal
rabbit serum (NRS) were tested for binding by incubating in
the presence of 125I-Tyr-SP and/or unlabeled SP. SPAb
specifically bound 20% of the counts added, these counts were
displaced by unlabeled SP. NRS did not bind any counts. Both
purified sera were checked in the LH RIA for interference or
crossreactivity. At the dilutions used in the bioassay
neither compound interfered in the LH RIA. In preliminary
studies a dose response curve for antibody-SP interaction
showed that a SPAb dilution of 1: 100 maximally bound SP but
did not interfere in the LH RIA. The SP Ab or NRS (at a final
dilution of 1: 100) was then added to cultured AP cells from
adult female rats for a period of 4 hours. Media was then
collected and assayed by LH RIA.
The results of four separate experiments, illustrated in
figure 8, show that in the presence of the SP Ab, LH released
into the medium was significantly elevated. This is an
unexpected result. If SP is stimulating LH release into the
medium, it would be expected that added SP Ab would bind any
released endogenous SP thereby preventing any action of SP to
stimulate release of LH into the medium. The question of
whether the SP antisera may have been contaminated with
enough SP to cause a response was approached by acid-acetone
extracting an amount of the SP antisera, equal to what was
used in the secretion assay, for measurement of SP in the SP
RIA. The results of the SP RIA showed that the SP antisera
was contaminated with SP but in an amount which would not be
capable of causing LH release. The amount of SP Ab used in
the secretion assay contained 56. 8 fmol SP. In 1 ml of
incubation media this would be a concentration of . 056nM, a
concentration too low to cause a stimulation of LH release.
Previous results reported here indicate a concentration of at
least 50 nM is needed to stimulate LH release.
There are some problems associated with using antibodies
as neutralizing tools. In some situations antibodies have
been reported to cause a clustering of receptors which is an
important first step in internalization of hormone receptor
complexes. For example, in an effort to develop pure
antibodies against the GnRH receptor, Conn (1986) incubated
GnRH antagonist dimers (2 molecules of GnRH pure antagonist
crosslinked with ethylene glycol bis succimmidyl succinate)
with immunoglobulin G antibodies which crossreact with the
antagonist, with the result that a dimer is bound at each Fab
terminus of the antibody molecule. GnRH antagonist and the
dimer are pure antagonists and do not evoke LH release.
However, when the antibody-dimer complex is incubated with
anterior pituitary cell cultures it acts as an agonist and
results in LH release. It is thought by the author (Conn
1986) that the antibody-antagonist complex is binding to cell
surface receptors for GnRH via an interaction of the
antagonist bound at Fab terminals with the receptor. The
antibody acts as a crosslinker to effect the aggregation of
receptors which stimulates the biological response.
Similarly, when cells are exposed to submaximal doses of
insulin, addition of anti- insulin antibodies enhances the
biological activity of insulin (Kahn 1978).
In the experiment reported here, SPAb may be increasing
the biological effect of the submaximal amount of SP already
bound to the antibody (56. 8 fmol) by causing an aggregation
of receptors. Alternatively, SPAb may bind SP released from
AP cells or SP already bound to SP receptors and subsequently
act to cluster SP binding sites to result in a biological
effect, LH release. An alternative hypothesis could be that a
closely related analog of SP actually inhibits LH release.
The increase caused by SP may be a result of competition with
the inhibitor or antagonist.
It is planned in the future to do an experiment in which
increasing doses of SP, with or without SPAb, will be added
to cultured AP cells from female rats. If SP Ab is enhancing
the biological response of the added SP, the dose response
curve to which SP Ab has been added will be shifted to the
left.
EFFECT OF SPAB ON LE SECRTION OF AP CELLS IN CtJLTUR
100
200
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FIGURE 8. Effects of immunoneutralization on
basal LH release from AP cells in culture. Short
term AP cell cultures were incubated in the presence or
absence of SPAb (1: 100 final dil) or NRS (1: 100 final
dil) for 3 hours, media was collected and LH measured.
Error bars represent the standard error of the mean of 
separate experiments. SPAB significantly stimulates LH
secretion (* . 05 versus NRS or control wells) 
Experiment#9-SP binding studies membranes
Results of the preceding experiments show that SP
effects the release of LH from cultured AP cells depending on
the age and sex of the rat used to prepare the cells. To
explore the possibility that these effects are mediated by a
receptor for SP, radioligand binding studies were done on AP
membrane preparations. Two separate reports (Kerdelhue 1985;
Larsen 1989) have demonstrated high affinity, saturable and
specific binding sites for SP in AP membranes from male and
female rats. Adenohypophyseal SP binding in females and males
of different ages was examined to determine whether
differences in SP binding could account for differential LH
release caused by SP. Experiments were carried out using the
protocols and conditions outlined by Kerdelhue as described
in the Materials and Methods. Shown in figure 9 are
representative curves from each animal model as fit by Graph-
Pad (ISI). The curves represent the non-linear least squares
regression fit of the data points. The data shown are
representative of 6-10 separate binding experiments for each
animal model. Binding results were analyzed by composite
analyses of competition binding experiments using the LIGAND
(Munson, 1983) program. Raw data was pooled before analysis.
The composite analysis of the competition data from female AP
membranes in 6 separate experiments yielded a K =135 nM and an
estimated capacity of 4. 225pmol/mg protein. Binding data from
10 experiments with male AP membranes yeild a Ko=43nM and a
capacity of 565 fmol/mg protein , and analysis of 6
experiments using juvenile male AP membranes yeilded a K =52
and a capacity of 624 fmol/mg protein.
Results of secretion experiments shown in the previous
pages demonstrate that in the female rat the concentration
required to stimulate LH secretion is lower than that
required in the male rat. Such data, particularly when
combined with the binding results of this experiment, are
compatible with the presence of spare SP receptors in AP
glands of female rats.
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TABLE 8
COMPARISON OF THE KD AND R. FOR SP IN AP MEMBRANES FROM MALE,
FEMALE , JUVENILE AND HYPOTHYROID RATS.
AP Membranes KD (nM)
(fmol/mg)
Adult Male
Adult Female
Juvenile Male
Hypothyroid Male
Hypothyroid Female
135
100
560
4200
620
1300
1900
The dissociation constants (KD) and the number of binding sites (R
were determined by a composite computer analysis (LIGAND) of
competitive displacement experiments in which data points from
several experiments were pooled. The number of experiments for
each determination were: adult male- 10, adult female- , juvenile
male (30 days of age)-6, hypothyroid male- , hypothyroid female-
Experiment# 1 0- Inhibition 12SIBHSP binding by
analogs
To determine the specificity of the SP binding site in AP
membranes, competition of unlabeled SP and selected analogs
was studied. The concentration of peptides required to inhibit
125IBHSP by 50% (IC ) was determined and these are listed in
the accompanying table of rank order of ligand potencies 
( %
of IC for SP) for the analogs used in the study. Selected
titration curves are shown in figure 10. The peptides studied
inhibited 125 IBHSP binding in a competitive manner, SP being
the most potent, followed by SPFA (SP free acid), a C-terminal
modification of the SP molecule.
The inhibition of 1251 BHSP binding to AP membranes by
SPFA raises a question as to whether the receptor is of the
NK1 subtype which has been described in brain , olfactory and
salivary gland. The modified C-terminal portion of the peptide
significantly reduces its ability to displace the radioligand
from the receptor. This would suggest that the C-terminal
portion of the peptide is important in its binding to
receptor. The ability of SPFA to displace the radioligand from
binding sites on AP membranes as well as its ability to cause
LH release from AP cells in culture would indicate that the C-
terminal portion of the peptide is not as important for
binding of the peptide as it is in brain, olfactory and
, ,
salivary membranes. In addition, studies of the NKI receptor
reveal a different specificity profile in that physalaemi
displaces ligand for the NK1 site in brain or salivary
membranes with almost equal potency as SP. In this experiment
physalaemin did not displace with any appreciable potency.
This would also suggest that the binding site being described
may be different from the NK1 receptor.
, . (
SPECIFIC BINDING
r- 0
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TABLE 9.
RECEPTOR BINDING AFFINITIES OF SP AND ANALOGUES
IC50 (M) Relative Potency
Substance P
SPFA
GnRH
Substance K
Physalaemin
Eledoisin
SP (1-
SP (7- 11)
Kassinin
0x10-
0x10-
0x10-
::10-
::10-
::10-
::10-
::10-
::10-
0037
-:.
0005
0005
0005
0005
0005
,
0005
FIGURE 10. Inhibition of 1251BHSP by SP and selected
analogs. Different unlabeled analogs of SP were used at
increasing concentrations to displace 1251BHSP from AP
membranes from male rats. Curves represent typical
experiments. Each experiment was repeated at least 3 times.
Experiment# 11- Inhibition 125IBHSP binding
di valent cations
In order to further examine the suspected differences in
'L. SP binding characteristics between NK1 receptor and the
putative SP receptor in AP membranes, the effects of divalent
cations on IBHSP binding were examined. Binding conditions
for NK1 receptor sites in CNS and salivary gland differ
greatly from conditions used for the binding experiments in AP
membrane preparations in this study. The binding conditions
used to study SP receptor characteristics by Kerdelhue (1985),
and which were followed in this study included no divalent
cations and contained 5mM EDTA in the buffer. However, the NK1
receptor in brain cortex membranes and salivary gland
membranes binds SP minimally in the absence of Mn++ or Mg++
which stimulate specific binding of SP by increasing the
number of high affinity receptors.
Another reason behind this study was that in order to
determine whether the interaction of SP with its AP binding
site is modulated by guanyl nucleotides as are NK1 receptors
and other receptors which are coupled to G-protein, it would
be necessary to include Mg++ in the assay buffer to increase
the receptor coupling to G-protein.
In this experiment specific SP binding was measured in
the presence of increasing concentrations of the divalent
cations Mg++ , Mn++ and Ca++.
The results shown in Figure 11 illustrate that Mn++ , Mg++
and Ca++ all inhibit 125 IBHSP binding to AP membranes at quite
'\ , ,
low concentrations, with Mn++ being most potent, and Ca++ the
least potent. In the previously described NK1 receptor in
brain and salivary membranes, SP binding is increased by
divalent cations with Mn++ being the most potent and Ca++ the
least. Binding was inhibited at room temperature (not shown)
and at 4 C equally. The divalent cations used inhibited
total and specific binding.
Inhibition of 125 IDHSP Binding by Divalent Cations
120
100
II Mg
II Mn
025
Divalent Ion Concentration (mM)
FIGURE 11. Inhibition of IBHSP binding bydivalent cations. Effect of increasing concentrations
(O-lmM) of the indicated divalent cations on
specifically bound IBHSP p esented as % of control (nodivalent cation) binding. Shown is a representative
experiment, one of 5 repititions, error bars represent
the standard error of the mean of triplicates.
Experiments# and 13-Inhibition 12SIBHSP binding
, by guany 1 nucleotides
The NK1 receptor recently cloned contains seven membrane
spanning domains and shows a sequence similarity to the
members of G-protein coupled receptors (Yokota 1989; Hershey
and Krause 1989). Evidence for coupling of receptors to G-
proteins has been obtained from radioreceptor assays in which
guanyl nucleotides inhibit the binding of agonists to their
receptors. The observation that SP binding in brain and
salivary gland is inhibited by guanyl nucleotides lends
support for a coupling of those receptors to a G-protein. No
such effects of guanyl nucleotides on SP binding in AP
membranes have been reported. In order to examine this
question the effect on SP binding of selected nucleotides was
studied. These experiments were done in the presence of . OlmM
Mg++ which is the highest concentration that does not inhibit
SP binding and 100~M guanyl nucleotides. The results shown in
Figure 12 show that the binding of the radiolabeled agonist
is not inhibited by the nonhydrolyzable analogs of GTP
, but
was slightly inhibited by GTP. To determine whether GTP
changes the affinity or the number of sites, the competitive
displacement of the agonist in the presence or absence of
100 GTP was studied. This experiment is shown in Figure 13.
A computer analysis of this data gives K values of 30 and 
nM in the absence or presence of GTP respectively, and
estimated B values of 530 and 670 fmol/mg protein in the
absence or presence of GTP respectively. The lack of greater
effect of GTP on Ko or Bmax discouraged further
experimentation in this area, but does not definitely rule
out a possible G-protein coupled mechanism in SP receptor
binding.
;. .
Inhibition of 125IBHSP Binding by Guanine Nucleotides
120
100
Control GTP GTP S Gpp(NH)p
Nucleotide (.1mM)
FIGURE 12. Effect of guany1 nucleotides on
IBHSP binding to AP membranes. The data 
presented as the % of specifically bound counts in the
absence of nucleotide. The nucleotides were tested at
100 and the BHSP was tested at . 2nM and 1nM.
DISPLACEMENT OF 12SmHSP BY SP IN THE PRESENCE AND ABSENCE OF GTP
120
100
I! - GTP
+ GTP
- 1 1 - 1 0 9 - 8 - 7 -
LOG SP CONCENTRATION (M)
- 5 - 4
FIGURE 13. Competitive displacement of 125IBHSP by
SP in the absence and presence of GTP. Increas ing
concentrations of SP were used to displace labeled
agonist in the presence and absence of 100 GTP and
01mM Mg++ Binding was done at C. The curves
represent the computer fitting of data points from one
experiment.
Experiment#14-Inhibi tion 125IBHSP binding in AP
membranes selective agonists for neurokinin
receptors
It has recently been shown (Regoli et al 1988) that the
natural neurokinin peptides are not selective for the
different neurokinin receptor subtypes. If more than one type
of neurokinin receptor is present in the anterior pituitary
it would be difficult to distinguish whether the observed
effects of SP in the AP are due to SP acting at an NK1
receptor site or SP acting at a SK or NKB receptor site. To
determine whether the observed SP binding in AP membranes is
due to SP binding to an NK1, NK2 or NK3 neurokinin receptor
subtype, the recently developed selective agonists,
(Sar9 , Met (02) 11) SP selective for the NK1 site), (Nle10) NKA (4-
10) (selective for the NK2 site) and(MePhe7)NKB (selective for
the NK3 site) were used in competitive displacement
experiments. The representative experiment in figure 14 shows
that the selective agonists for the NK1 site and the NK3 site
displace 125IBHSP on AP membranes. These agonists have been
reported to discriminate quite well between the three
receptor subtypes and are being used widely to classify
neurokinin receptors. The results of this experiment suggest
that there are at least two neurokinin receptor subtypes in
the anterior pituitary, the NK1 subtype and the NK3 subtype.
This result is surprising because SK, the endogenous ligand
at the NK2 site, stimulated LH release from cultured AP cells
from female rats, yet the NK2 selective agonist did not
displace the radioligand. This would imply that SK may be
crossreacting at the SP binding site to cause the effect on
LH secretion. It is not known whether NKB has any effects on
AP hormone secretion. In this study it did not affect LH
secretion.
Displacement of 125IBHSP binding by selective SP receptor agonists
120
ii SP
NKI
a NK
o NK
100
- 1 1 - 1 0 9 - 8 - 7 -
Peptide Concentration(log M)
- 5 - 4
FIGUR 14. Competitive displacement of 125IBHSPbindinq by neurokinin receptor selective
aqonists. Increasing concentrations of synthetic
agonists. elective for the NK1, NK2 and NK3 neurokinin
receptors were used to displace 
125IBHSP binding to AP
membrane preparations along with increasing
concentrations of SP as a comparison. The curves
represent the computer fit of the data points of a
representative experiment which was repeated 4 times.
Experiment #lS-Competitive displacement 125IBHSP
unlabeled SP in AP membranes from normal and
hypothyroid rats.
SP concentrations in the AP are increased in
hypothyroidism, however, LH release in response to SP in
cultured AP cells from hypothyroid female rats is
significantly reduced. In order to determine whether the
reduced LH response in AP cells from hypothyroid rats is due
to a change in binding parameters or Bmax
) , 
a competitive
displacement of labeled SP binding to hypothyroid AP
membranes was carried out with normal AP membranes as a
control. An anterior pituitary gland from each group was
extracted in 2N acetic acid and assayed for SP using SP RIA.
Hypothyroid glands contained 579 fmol SP/gland and normal
glands contained 270 fmol/gland. A composite analysis of the
data from 4 separate experiments using the LIGAND program
resulted in a K = 35 nM and a Bmax = 553 fmol/mg of protein
for the SP binding in control or normal AP membranes and a 
= 100 nM and Bmax =1. 325 pmol/mg protein. An aliquot of the AP
membranes were extracted in 2N acetic acid and assayed for SP
to determine whether membranes from hypothyroid animals were
contaminated with endogenous SP which would interfere with SP
binding experiments. It was found that hypothyroid membranes
contained more SP than membranes from normal rats.
Hypothyroid membranes contained 163 fmol SP /mg of protein and
control membranes contained 53 fmol SP /mg protein. This
difference did not interfere significantly with binding.
IN. OF 125IBHSP BY SP IN AP MEMBRANS
FROM NORMAL AND HYOTHYROID RATS
120
100
- 1 1
- 9
- 8
I! Control
Hypthyroid
- 7 - 6
- 5 - 4
SP Concentration (109M)
FIGURE 15. DispJ.acement of 125IBHSP by unJ.abeJ.ed
SP in normaJ. and hypothyroid animaJ.s. Increas ing
concentrations of unlabeled SP were used to displace
2nM 125IBHSP binding from AP membranes of normal and
hypothyroid rats. Curves represent a computer fit of the
data points from a representative experiment which was
repeated 4 times.
, ', ', .
Experiment#16-Displacement 125IGNR binding to AP
membranes unlabeled
The question of whether SP acts to stimulate the
secretion of LH in cultured AP cells by acting at a GnRH
receptor was addressed in this experiment by examining the
displacement of 125 IGNRH by increasing concentrations of
unlabeled SP in AP membranes from female rats. The 125 IGNRH
was purchased from NEN and is the radioiodinated native GnRH
molecule not one of the newer synthetic analogs which have a
higher affinity for the binding site and do not degrade
during the course of the incubation. The use of labeled
analogs of GnRH abolished the problem of low affinity binding
in GnRH radioreceptor assays (Clayton and Catt, 1981). For
the purposes of this study, to determine whether SP could
displace GnRH at its receptor site with any potency, the
native molecule was an appropriate ligand. The assay was
carried out using the procedure of Clayton and Catt (1981)
which was very similar to the procedure used for SP binding
in AP in the previous experiments. The results show that SP
has very little potency to displace GnRH at its binding site
with an IC50=10~M. This would probably not be a physiological
concentration of SP in the anterior pituitary. This
experiment provides evidence that SP is probably not acting
at a GnRH receptor to stimulate LH secretion.
100
IN. OF 125IGNRH BINING BY GNRH AND SP IN AP MEMBRANS
120 GnRH
100
.J'
- 1 1 - 9 - 8 - 7 - 6 - 5 - 4
LOG PEPTIDE CONCENTRATION rM1
FIGURE 16. Displacement of 125 IGNRH binding by SP in AP
memranes. Increasing concentrations of SP were used to displace
labed GnRH from AP membranes. The curve represents the best
computer fit of the data points of a representative experiment
which was repeated 3 times. Each data point is the average oftriplicates. 
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TABLE 10,
COMPARISON OF SP BINDING CHARACTERISTICS IN ANTERIOR PITUITARY
AND SALIVARY GLAD MEMBRANES
Binding Salivary
Parameter Membranes Membranes
(Male Rat)
50 nM 1 nM
BMAx 565fmol/mg 550fmol/mg
Divalent Inhibits Increases
Cation Binding (::,05mM) Binding (2, 10mM)
(Mg++ Ca++ Mn++)
Guanyl No Effect Reduce
Nucleotides Affinity
Second Unknown Phosphatidyl
Messenger Inositol
Specificity SP:PF A:K: SP=Physalaemin::
Physalaemin SK::SPFA
This table was compiled to examine the differences between the SP binding site
in the AP and NK1 receptor in salivary gland membranes. The comparison points
out the many dissimilarities between the two binding sites and could argue for a
novel sub type of SP receptor,
DISCUSSION
The Effect of SP on LH Release from AP CellsCulture
This thesis clearly demonstrates that SP can stimulate
LH release in short term cultures of anterior pituitary cells
and that the SP stimulation of LH release varies as a
function of age and sex. In cultured AP cells from
prepubertal female rats there is no significant effect of SP
on LH release. However, after day 30, coincident with the
onset of puberty, an increase in the response to SP occurs
which continues throughout adulthood. AP cells from male rats
also become highly responsive during the peripubertal stage
(ages 30-40 days) but fail to respond after the animal
reaches adulthood (ages 50 days and above) 
These results differ from those reported by Kerdelhue
(1979). He reported no stimulation of LH secretion by SP at
doses up to l~M using AP cells from adult female rats.
However, his cells were kept in culture for 7 days prior to
stimulation with SP. It was subsequently shown (Baldwin and
Downs 1981) that cultured cells only maintain their
characteristic estrus cycle responsiveness for 18 to 24
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hours. After 7 days in culture AP cells may have lost certain
secretory characteristics and responsiveness that they may
have had in vivo or after shorter periods in culture.
Kerdelhue also found that in anterior pituitary cultures from
female rats at different stages of the estrus cycle, SP
(100nM) inhibited GnRH (10nM) stimulated LH release from AP
cells of proestrus rats. The inhibition by SP of GnRH
stimulated LH release in AP cells from proestrus rats was not
seen in AP cells from random cycling females which were used
in the present study. This inhibitory effect of SP could have
been obscured by the pooling of rats from different stages of
the estrus cycle.
The results of the present study do agree with those of
Fisher and colleagues (1974) who reported that SP (10~M)
stimulated LH release in hemipituitaries of female rats.
Also, there is a supporting in vivo experiment (Debeljuk
1987) in which SP antiserum injected intravenously results in
reduced LH secretion in estrogen treated male castrates but
not in untreated intact males. Although it shed no light in
terms of the site of action, this experiment supports the
findings reported in this thesis and also suggest that the LH
stimulating effect depends on the hormonal status of the
animal.
Among the tachykinins studied, SP is the most effective
in inducing LH secretion by AP cells in culture. NK1, the
selective agonist for the SP receptor (Regoli et aI, 1988)
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stimulated LH release only slightly. It was expected that, if
SP were stimulating LH release via a typical NK1 specific
receptor NK1 agonist should stimulate release with almost
equal potency as SP. This raises questions about the potency
of the NK1 selective agonist and also suggests the type of
binding site being characterized in the present study may be
different from NK sites previously described. The NK2 and NK3
selective agonists do not stimulate LH release, although the
NK3 agonist does displace binding of 125IBHSP in AP membranes.
There may be a fourth kind of tachykinin binding site or the
response may not involve binding to a true receptor. SPFA,
which has little potency to displace labeled ligand from
brain cortex and salivary gland SP specific receptors, has
bioactivity and also displaces labeled ligand with almost
equal potency to SP, suggesting that the native intact c-
terminal is not important in binding or bioacti vi ty. This
implies that the SP binding site in anterior pituitary could
be different from previously described SP receptors. SK
stimulates LH release, however, it does not displace labeled
ligand in SP binding studies. It is possible that SK (an
aliphatic tachykinin) has difficulty in displacing 
125 IBHSP (a
more hydrophobic molecule) which may have a higher affinity
for the receptor. If this is the case SK may be acting as an
agonist at a SP receptor, as tachykinins are known to be not
perfectly specific.
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Effects of the Bormonal Milieu on the SP Response
Gonadal Steroids
Attempts were made in the present study to manipulate
the hormonal milieu of anterior pituitary cells in culture in
order to determine the effects of gonadal steroids on SP
stimulated LH release in both male and female rats of
different ages. Other researchers have had much success in
studying the regulation of LH secretion with direct
incubations of cultured pituitary cells in estradiol or DHT
(Ramey, 1987; Tang, 1978; Hubert, 1988). The advantage of
this method is that direct effects of gonadal steroids at the
level of the anterior pituitary can be studied. The
disadvantage is the difficulty of simulating the appropriate
levels of gonadal steroids in order to analyze a true
physiological response. In the present study attempts were
made to affect the lower sensitivity of AP cells from adult
male rats by a direct action of androgens at the level of the
AP by incubating AP cells from peripubertal male rats in the
presence of androgens. This experiment shed no light on
whether the response to SP can be regulated by gonadal
steroids because basal levels of LH secretion were so high
that even the response to GnRH was obscured. This result is
interesting in that it could be a hint of a positive feedback
action of androgens at the level of the AP during the onset
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of puberty in male rats. This has never been reported,
although there are reports of reduction in the sensitivity
to the negative feedback action of androgens at the time of
puberty.
In experiments where DHT silicon capsules were implanted
into female rats at 24 days of age the result was a decreased
sensitivity to 100nM SP. This would suggest that circulating
androgens can affect the sensitivity of the responsiveness of
the AP to SP. However, at higher doses of SP there was no
difference in the response to SP between AP cells from
control and DHT treated animals. This would suggest that a
complete conversion to the male pattern had not been
affected. In future experiments longer times of DHT exposure
will be used for this experiment and SP binding studies will
be carried out on AP membranes from the experimental groups
to determine whether any differences in sensitivity could be
correlated with differences in binding parameters.
Thyroid status
The thyroid status of the animal has been shown to
, ,
regulate the amount of SP present in the anterior pituitary
(Aronin et aI, 1984). Chemically induced hypothyroidism can
raise the SP levels in female rat anterior pituitaries to
that of the level of SP in adult males. It was reasoned that
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if the higher SP concentrations in the adult male rat
anterior pituitary gland are in some way linked to the lack
of LH release in response to SP in that animal, AP cells from
hypothyroid females may respond similarly to AP cells from
adult males. Cultured AP cells from female rats made
hypothyroid experimentally by addition of methimazole to
their drinking water for 21 days were treated with SP in
order to determine whether hypothyroidism has any effect on
SP stimulated LH release. The dose reponse to SP in AP cells
from hypothyroid female rats resembled that of the normal
adult male, in that the LH response to SP was attenuated. Yet
in the dose response to SP in cells from intact male and
females there was no difference in the LH released in
response to GnRH. Therefore only a very weak correlation
could be made with the attenuated LH response in cells from
normal male rats which contain, as in the hypothyroid female,
higher concentrations of SP in the anterior pituitary gland,
but whether these two phenomena are causally related or
simply nonspecific in nature is not known.
The response to GnRH is also decreased in AP cells from
hypothyroid female rats. This raises the possibility that the
reduction in LH response to SP is nonspecific in nature and
may be due to other effects of hypothyroidism. A lower LH
content in cultured AP cells from the hypothyroid animal
explains the reduction in LH secretion in response to GnRH
and SP.
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Hypothyroidism in female rats has been shown to reduce
LH and FSH release and to disrupt ovulation (Hagino, 1971).
In male rats thyroidectomy results in reduced LH and FSH
release and reduced serum testosterone (Bruni et aI, 1975).
In a contrasting report, Kalland et al (1978), found no
difference in basal serum LH, FSH and testosterone levels
between euthyroid and hypothyroid males. However, in both
male and female rats, hypothyroidism results in higher serum
LH and FSH levels after gonadectomy (LaRochelle and Freeman,
1973; Bruni et aI, 1975), or at 15 minutes after acute GnRH
administration (Kalland et aI, 1978). Taken together these
data imply a relationship in the secretory control mechanisms
between gonadotrophs and thyrotrophs. The mechanism by which
thyroid hormone acts to modulate gonadotropin release is not
known. Available evidence is consistent with the speculation
that SP may be a common anatomical (SP has been localized in
both thyrotrophs and gonadotrophs) and perhaps functional
element in both thyrotrophs and gonadotrophs (Morel, 1982;
DePalatis, 1984), the levels of which are regulated
differently by thyroid and gonadal status (Coslovsky et aI,
1985). The results presented in this thesis demonstrate that
hypothyroidism in female rats shifts the bioactivity profile
for SP to one resembling that seen in the normal adult male
rat. This is consistent with the finding that in
thyroidectomized females there is a reduction in serum LH and
impaired ovulation and fertility.
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Measurment of Basal. LB Rel.ease in the Presence of a
Neutral.izing Antibody
The lack of an antagonist to SP or a known physiological
stimulus for release of endogenous SP has made it difficult
to show experimentally that APSP could be acting in a
paracrine or autocrine way to affect LH regulation. The
question of whether SP can be released from AP cells to act
in a paracrine or autocrine way to cause LH release was
approached in this study by incubating cultured AP cells from
adult females in the presence of a purified SP antiserum with
the expectation that this would bind released endogenous SP
thereby reducing basal LH secretion. However, SPAb added to
AP cell cultures for 4 hour incubations had the unexpected
effect of stimulating LH release rather than reducing it.
Much preliminary work was done to insure that this effect was
not artifactual. Equivalent wells were incubated with non
immune rabbit serum as a control. This treatment did not
stimulate LH release. In order to eliminate proteins other
than immunoglobulins in the SP antiserum and the normal
rabbit serum, an ammonium sulfate precipitaion of antibody
was done on both serums. The purified SPAb and NRS were
checked for crossreactivity or interference in the LH assay.
It was found that at the concentrations used in the cell
incubations there was no interference in the LH assay with
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either compound. Therefore, it appears that SPAb itself
11-
affects LH secretion. The SPAb was contaminated with a small
amount of SP (60 fmol) but certainly not enough to cause a
stimulation of LH secretion which requires 50 to 100 nM SP.
Alternatively, SPAb could be binding endogenously released
SP, each arm of the immunoglobulin binding one SP molecule
stimulating a capping or bridging of receptors and
potentiating what might in the absence of SPAb be a small
effect. Precedence for this kind of phenomenon comes from
studies on GnRH receptor microaggregation for which a
molecule consisting of a GnRH pure agonist bound to an
antibody which crossreacts with the antagonist was used to
probe receptors (Conn, et aI, 1986). Surprisingly the molecule
behaved as an agonist. When the antibody was cleaved and
reduced, the monofunctional antibody-antagonist complex
returned to antagonistic behavior. This experiment showed
that an antagonist could be converted into an agonist by
linking the two antagonist molecules giving them the ability
to stimulate microaggregation of receptors. If SPAb is
binding the C-terminal ends of endogenously released APSP,
the extended N-terminal ends of the peptide would still be
available to bind to receptor and the Ab bridge could
stimulate receptor microaggregation. The specificity data
reported in this thesis, which showed that C-terminal
modifications did not reduce the biological effect or the
binding of SP to AP membranes, support the concept that the
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receptor could be stimulated by the N-terminal portion of the
molecule.
Binding Sites the Anterior Pituitary Gland
Like other neurotransmitter and peptide hormones, the
effects of SP are initiated by binding to target cell
receptors. It is possible that one of the sites of action of
gonadal steroids is at the membrane receptor level to
modulate the extent of SP binding and LH release in the
female. A correlation between receptor regulation and target
organ receptiveness has been demonstrated for several
hormones, including gonadotropins (Savoy-Moore et aI, 1980),
somatostatin (Schonbrunn and Tashjian, 1978), and TRH
(Perrone and Hinkle, 1978). It was hypothesized that the
enhanced LH response to SP in female anterior pituitary cells
was due to an increase in the affinity or number of SP
receptors in the female. SP binding sites in female rat
anterior pituitary membranes were initially reported by
Kerdelhue et al (1985). Results presented in this thesis are
consistent with some of the findings of Kerdelhue et al
although estimates of receptor affinity and density were
somewhat different. They report a Kct= 1. 20 nM and a Bmax=160
fmol/mg. In the present work, a composite analysis of SP
binding to anterior pituitary membranes from male rats using
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the LIGAND computer program generated a Kd=42nM and a Bmax=570
fmol/mg, whereas analysis of SP binding to anterior pituitary
membranes of female rats yielded a Kd=130 and a Bmax=4. 2
pmol/mg. These binding characteristics differ from those
reported by Kerdelhue. These differences could be explained
by the different radioligands used in the two studies.
Kerdelhue did not use 125IBHSP, but instead used 3HSP or a
ITyr-SP. The different radioligands could be binding to
different SP binding sites in the AP or binding with more or
less affinity to the same binding site. However, allowing for
the differences in Kd and Bmax the results of the present study
confirm the hypothesis that there is an increase in the
number of binding sites in the female rat anterior pituitary
which could be responsible for the enhanced effect of SP in
these animals. A direct correlation is confounded by the
slightly decreased affinity SP binding in the female rat.
However, the large increase receptor number could explain
the difference response, whereas the slight decrease
affinity could be due to an increase in the number of both
high and low affinity sites, with the large number of low
affinity sites obscuring the ability of the assay to detect
the higher affinity sites.
The finding that AP cells from females have greater
sensitivity to SP and a far greater number of receptors is in
keeping with the concept of spare receptors (Nickerson 1956).
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Spare receptors modulate the hormone sensitivity of the cell.
The kinetics of hormone receptor binding follow the laws of
mass action, to illustrate: H+R- HR- Biological Response.
The critical concentration is that for HR and this is
determined by concentration of both the hormone (H) and
receptor (R). By increasing the (R) the reaction can be
driven to the right. The higher (R) is, the less (H) is
required to reach the same concentration of HR. As a result
the cell is more sensitive to H. A teleological explanation
of this phenomenon was given by Goldstein (1974). He suggests
that in circumstances where a rapid onset of response and a
rapid termination of response is required, a spare receptor
capacity provides a mechanism for obtaining a response at a
very low concentration of agonist which has a relatively low
affinity for the receptor. The low affinity of the agonist
assures a rapid rate of dissociation. If high affinity of the
agonist for the receptor was used to achieve sensitivity then
the rate of reversal of the effect would be slow.
There was no evidence of a second binding site in any of
the animal models studied (the inclusion of a second binding
site did not improve the computerized fitting of the data)
although the displacement curve is shallow giving the
illusion of multiple binding sites. One of the problems with
the assay is that native SP is susceptible to proteolysis,
even at 4 . Thus it is difficult to accurately set the
concentration of SP at each point. Furthermore degradation
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probably occurs at different rates at different
concentrations of SP resulting in the shallow appearance of
the curve. Peptidase inhibitors were not used in the assay as
they decreased SP binding.
Direct correlation of binding characteristics with
biological effects is difficult in the case of the SP binding
experiments in AP membranes from hypothyroid male rats as
well. As mentioned above, there are conflicting reports on
whether hypothyroidism in male rats causes an increase, a
decrease or no change in serum LH levels. The present SP
radioreceptor assay study of AP membranes from hypothyroid
male rats showed a doubling of receptor number and a slight
decrease in affinity of the receptor. Binding studies done on
AP membranes from hypothyroid female rats resulted in a
=48nM and Bmax=l. 9 pmol/mg prot. These values are different
from control female values (Kd=135 and Bmax=4. 2 pmol/mg) and
are changing in the direction of the binding parameters in
male AP membranes. This correlates with the reduced LH
response to SP in AP cells from hypothyroid female rats. This
would suggest that SP may be partially responsible for the
reduced LH secretion in hypothyroid female rats, however this
does not explain the reduction of LH release in response to
GnRH.
Radioreceptor assay does not distinguish between
functional and nonfunctional receptors and may not be
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accurate enough to distinguish between two or more distinct
subtypes of tachykinin receptor. The sensitivity of the
radioreceptor assay approach may not be optimal for the
quantitation of changes in SP receptors in different
physiological states because of the lack of a highly
purified, synthetic, non-degradable analog of SP which could
be used as a probe for high affinity SP binding sites.
Very similar problems were encountered in the attempt to
establish a radio receptor assay for GnRH. Early
investigations were done with iodinated GnRH as the
radioligand (Clayon and Catt, 1981). It was found that labeled
GnRH interacted predominantly with a very low affinity (Kd=10-
6M) binding site with a very high capacity for GnRH. Only a
small percentage of tracer bound to sites of reasonably high
affinity (Kd=10- M). It was found that there was significant
tracer degradation even when assay incubations were done at
C (Clayton et aI, 1979). Since then agonist and antagonist
analogs of GnRH have been synthesized for biological and
binding studies. These analogs had a slower rate of
degradation by pituitary peptidases, prolonged action on LH
release and interacted selectively with specific high
affinity binding sites. Hormone analogs have been validated
as probes for analysis of several physiological receptors and
have been of primary importance in the field of hormone
receptor research.
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Effect of Divalent Cations on SP Binding in AP
In spite of the lack of sensitivity of the radio
receptor assay for studying the regulation of high affinity
binding sites, the present binding studies have provided some
important and novel observations. Attempts were made to
examine the possibility that the action of SP may be mediated
through coupling with a guanine nucleotide binding protein.
It was found in the course of these studies that SP binding
is inhibited over 80% by 1 ro magnesium and 95- 98% by 5ro
magnesium, concentrations that are required for optimal high
affinity binding of SP in brain tissue (Cascieri and Liang,
1983). While it is possible that magnesium enhances the
activity of peptidases in the pituitary, causing the ligand
and perhaps the receptor to degrade, it is not likely since
magnesium inhibits binding equally at 37 and 4 C and
peptidases are inactive at 4 C. Another possibility could be
that Mg++ promotes coagulation of vesicles effectively masking
binding sites. To determine whether this was true anterior
pituitary membranes were pretreated with saponin. Saponin
pretreatment had no effect on control binding or on the
inhibitory effects of magnesium (data not shown). The present
studies also demonstrate that SP binding is inhibited by
calcium to a lesser extent than magnesium and by manganese
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which is even more potent than magnesium. Perhaps the SP
receptor is a calcium channel or is coupled to a calcium
channel resulting in a competition for binding at the site or
an uncoupling of SP-bound receptor in the presence of
calcium, magnesium or manganese. Alternatively magnesium and
calcium may stimulate release of stored SP in synaptic
vesicles in the anterior pituitary membrane preparation
resulting in a competition for binding with exogenous
ligands.
The inhibition of binding by divalent cations,
particularly Ca++ and Mg++ was a common characteristic of GnRH
receptor binding (Marian and Conn, 1980). This study
demonstrates that Ca++ inhibits binding of a superactive
analog of GnRH in spite of the fact that GnRH does not
stimulate LH release in the absence of extracellular calcium.
This suggests that the action of Ca++ occurs after hormone
receptor binding. This is consistent with the fact that
increasing intracellular calcium by means of ionophores or
depolarization alone is sufficient to cause LH release. TRH
binding to bovine anterior pituitary membranes is inhibited
by Ca++ at all concentrations tested and by Mg++ and Mn ++ at
concentrations greater than 2. 5mM as reported by Labrie et al
(1972). This characteristic of releasing factor receptor
binding has not been adequately explained and the mechanism
of divalent cation inhibition of binding at the level of the
receptor is still unknown, and is particularly perplexing
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because of the absolute requirement for Ca++ during signal
transduction and for the final biological response.
Differences Between SP Binding Sites in the AP and the
NKl Receptor
Some of the above mentioned characteristics of the SP
binding site in the anterior pituitary distinguish it from
the classical NK-1 site which has been previously described
in brain, salivary and submaxillary gland membranes (Bahouth
and Musacchio, 1985; Cas cieri and Liang, 1983; Lee, et al.,
1983). Some of these differences include 1) Kd and Bmax, the
classical NK-1 site is a higher affinity (lnM) lower capacity
site; 2) G-proteiri coupling, it has been confirmed that
guanine nucleotides have an inhibitory effect on SP binding
to the classical NK-1 site, whereas guanine nucleotides do
not appear to inhibit SP binding to the binding site in AP
membranes; 3) divalent cations, Mn++, Mg++ and Ca++ increase SP
binding in brain, salivary and submaxillary membranes with
maximum effects at 5mM, wheras in AP membranes SP binding is
significantly inhibited in the presence of divalent cations
even at concentrations as low as . 1 mM; 4) specificity, for
the NK-1 receptor the rank order of potencies is
neurokinin B, and the nonmammalian peptides physalaemin
(almost equal potency to SP) eledoisin kassinin, however in
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the AP membrane physalaemin has almost no potency to displace
SP, nor does SK, the C-terminal modification of SP in SPFA
does displace SP with an IC50 of 10- as does GnRH with an IC50
of 10- . These differences in receptor characteristics raise
the question of whether this binding site is an unknown
tachykinin receptor subtype or another receptor with some
affinity for SP. There is an increasing body of evidence that
strongly supports the existence of an N-terminal directed SP
receptor which mediates distinct biological activities of N-
terminal metabolites of SP (Stewart 1982; Skilling 1990).
In light of the similarities between the SP binding site
in the AP and the GnRH receptor and the differences between
the APSP binding site and the salivary gland SP receptor, the
question of whether SP may be acting at a GnRH receptor was
addressed. Indeed, some conformational and structural aspects
of the undecapeptide, SP, may provide slight acceptability at
the receptor site for the decapeptide, GnRH. It has been
postulated that the driving force for the formation of
hormone-receptor complex in GnRH interaction with its
receptor is probably an ionic interaction between the amino
acid Arg in position 8, which is positively charged, and the
negatively charged carboxyl groups in the binding site. The
hormone-receptor complex may be stabilized by aromatic x-x
interactions between the histidine, tryptophan and tyrosine
moieties of the hormone and the tyrosine and tryptophan
moieties of the binding site (Hazum and Conn, 1988). The Arg
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moiety of SP in the protonated form could be very important
for activity and potency because it contributes an ionic
nature to the molecule, the Lys moiety could make a similar
contribution. The Phe-Phe moieties could contribute
structural specificity to molecule and allow possible 
x-x
interactions with the GnRH receptor site. Indeed, SP has some
potency to displace 125IGnRH from AP membranes (IC5o=10
suggesting that at higher concentrations SP could act at a
GnRH receptor.
The physiological relevance of the effect of SP on LH
release from anterior pituitary cells has been addressed from
the aspect of whether local SP concentrations in the anterior
pituitary could possibly get to 100nM, the concentration used
to stimulate LH release from cells in culture and the IC
competition binding curves. In the case of a paracrine or
autocrine effect SP would be released to act directly in the
area of release. It has been shown that SP can be released in
a K+ stimulated, Ca++ dependent manner from hemipituitaries,
and that the amount released was almost equal to the total
amount of SP contained in the gland before stimulation
(Aronin 1984). In other words, upon appropriate stimulation a
pituitary cell could release its entire contents of SP into
the extracellular space. The concentration of SP in the
anterior pituitary is =200 fmol per gland in the female rat
and =400 fmol per gland in the male rat. There are
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approximately 4. Ox10 cells per pituitary (Ben-Jonathan et
al, 1983) and these cells are approximately 10-15 ~m in
diameter. Cell volume can be estimated using the formula for
the volume of a sphere (. 5pL) and assuming the 1: 1
relationship between cell volume and the trapped volume
between cells, the extracellular volume would be estimated to
be . 5pL. The volume of the extracellular space in an entire
anterior pituitary gland would be 4. Ox10 cells/pituitary x
5x10-12 L =2x10- L or 2~L. Assuming 200x10- moles of SP was
released into the extracellular volume of 2~L (200x10- 5/2xlO-
6) a concentration of 100nM would be reached assuming uniform
dispersion. Thus, it is possible that SP can reach levels
sufficient to activate LH release in vivo.
A possible Physiological Releasing Factor for
A physiological factor which stimulates SP release from
AP is not known. However, a recent abstract (Calvo 1989)
reports a significant stimulation of SP release when compared
to basal release from perifused anterior pituitaries from
normal male rats in response to 10 minute infusions of TRH
(10nM-1~M). GnRH was also tested and no effect was observed
on SP release. I have also observed SP release in response to
TRH in AP cells in culture from both intact males and
hypothyroid males. However, out of 10 experiments, 5 resulted
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in SP release in response to TRH (100nM) and 5 were negative
(data not shown). I also observed no SP release in response
to GnRH (10nM and 100nM). In future I would like to pursue
these experiments in animal models which have higher SP
levels in the AP to increase the chance of SP being released.
I will also try AP cells from rats which are more sensitive
to SP, such as female or peripubertal male rats, with the
idea that since AP cells from these animals can respond to SP
in vitro maybe these models have release mechanisms for SP
already in operation in vivo.
Another method of optimizing the cell' s ability to
release SP in response to TRH, would be to attempt to
increase the number of TRH receptors on AP cells. Prolactin
release by TRH is enhanced by estrogen, presumably by an
action of the steroid on the number of TRH binding sites on
lactotrophs (Gershengorn 1979). Also, TRH receptor number
fluctuates during the rat estrous cycle being minimal at
diestrus and maximal on the evening of proestrus (De Lean
1977). Perhaps the use of AP cells from rats at proestrus or
the treatment of AP cells with estrogen would increase the
chances of observing SP release from AP cells in response to
TRH.
If TRH does act as a physiological releasing factor for
SP, estrogen, by increasing TRH receptors, may be a factor
involved in this action. This idea would be consistent with
the lower SP concentrations in the anterior pituitary in the
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female rat. An increased rate of SP release could be one of
the mechanisms keeping SP concentrations lower than in the
male. This concept would also be compatible with the
increased sensitivity to SP observed in AP cells from female
rats. In other words estrogen may be the common factor, which
increases TRH receptor number, SP release and SP binding
sites and thereby allowing the action of SP to increase LH
release in the female rat. Future studies will involve the
treatment of estrogen primed AP cells with TRH, perhaps using
a perifusion apparatus rather than a static culture system to
facilitate observations at shorter time points. TRH receptors
may also prove to be the link between thyroid status and LH
secretion.
Speculation the Factors which could be Responsible
for the Sex Difference in Stimulated LH Release
The regulation of gonadotropin secretion is mediated by
a combination of sexually dimorphic and developmental
neuroendocrine mechanisms. However, it is difficult to
determine whether apparent sex and age differences in the
sensitivity to SP are caused by developmental and sexual
dimorphisms (such as differences in LH content or number of
responding gonadotropes) or whether SP plays an important
role in the maintenance of the sex and age differences in LH
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regulation.
At the AP level there have been numerous reports of sex
differences in the content of AP hormones. However, since
hormone content at any time is the result of a dynamic
process of synthesis and secretion these reports shed little
light on the process of LH regulation at the level of the AP.
Cicero et al (1986) reports that adult male APs contain 5
times more LH than female APs. Whether this higher content is
a result of lower secretion of LH by males is not addressed
in the that study. Other regulatory peptides show content
differences depending on the hormonal status of the animal.
Morphological differences in gonadotropes and
differences in cell number have been reported in relation to
sex, estrous cycle and age (Tougard and Tixier-Vidal 1988).
Although gonadotropes represent approximately 14% of the
anterior pituitary cell population of normal adult male and
female rats, there is a sexual dimorphism in the size of
gonadotropes. In male rats gonadotropes range in size from
30-160~m2 in area while in the female rat gondotropes are from
130-170 . There is also a sex difference in the percentage
of multihormonal LH/FSH cells in the rat. In the female
multihormonal cells account for 37-40 % of gonadotropes as
compared with 70 % in the male. Perhaps it is the
monohormonal cells which are more abundant in the female
which are sensitive to SP. Although there is no change in the
absolute number of gonadotropes throughout the estrous cycle,
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a decrease in the percentage of monohormonal cells at
proestrus suggests that these cells are involved in the LH
surge.
Layered onto this morphological complexity is the
complexity of differential sensitivity of gonadotropes to
circulating regulatory factors such as gonadal steroids,
GnRH, other hypothalamic peptides and AP peptides which may
be released by neighboring cells to modulate the release of
LH. The speculation that the multihormonal and monohormonal
gonadotropes are regulated differently (perhaps mediated by
differential sensitivity to regulatory peptides) would be
compatible with the results of the present study. There are
changes in gonadotrope cell number and size during
development. Gonadotropes increase during the first week of
life to a percentage which is higher than the adult, with a
higher cell number in females than in males. It is not known
whether these are multihormonal or monohormonal. A higher
percentage of gonadotrophs which are responsive to SP at the
time of puberty in the male rat would be consistent with the
findings reported in this thesis.
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Regulation Secretion independent of Mediation
GnRH .
The focus of the ensuing paragraphs will be on the
mechanisms by which the gonadal steroid environment can
regulate LH secretion from the anterior pituitary,
independent of variations in GnRH secretion, in an attempt to
evaluate the possibility that a paracrine or autocrine action
of SP may provide an intrapituitary mechanism for LH
regulation. The evidence from GnRH receptor work indicates
that the regulation of GnRH receptor is not a major mechanism
for hormonal modulation of gonadotroph sensitivity. This is
thought to be conferred by changes in post- recepto events
and perhaps other mechanisms which have not been defined as
yet (Clayton, et aI, 1985) .
Stimulation of LH Release by in Female Rats
Ther are several reports indicating that the pituitary
is the site of estrogen and progesterone action regulating
the release of LH. This would require gonadal steroid
regulatable mechanisms within the anterior pituitary.
Peptides which are synthesized and whose concentrations are
regulated by gonadal steroids in the anterior pituitary would
be ideal candidates to mediate such mechanisms. Sustained
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estrogen action has been shown to increase the releasable
stores of LH in the pituitary (Kalra and Kalra 1974;
Pickering and Fink 1979), and the gradual enhancement in LH
secretion in response to GnRH stimulation is directly related
to the concentration and duration of pituitary exposure to
estrogen. On the other hand, a progesterone milieu during the
afternoon of estrus through noon of diestrus II, results in
the gradual decline in pituitary responsiveness to exogenous
GnRH. In a study investigating the change in responsiveness
of dispersed pituitary cells in perfused columns, Speight and
Fink, (1981) demonstrated that the LH response to GnRH from
cells prepared from rats at proestrus were much greater than
that of rats killed at other times of the cycle. This
difference was seen when cells were stimulated with 60 ro 
suggesting that at least part of the increase in pituitary
responsiveness at proestrus is not dependent on changes in
specific GnRH receptors. Perhaps an increase in the
releasable pool of LH and/or increased sensitivity to
regulatory peptides could account for the extra LH released
over and above LH release mediated through GnRH receptors.
Tang et al (1982) have shown that estrogen effects on
pituitary LH responses to GnRH in vitro can be both
inhibitory and stimulatory depending on the concentration and
time of the estrogen exposure. They demonstrate that the
estrogen priming effect on pituitary LH response to GnRH is
initially associated with an increase in cellular LH content,
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then with increases in GnRH binding and in an index of cell
proliferation which may include LH producing cells.
More evidence of the pituitary s participation in the
feedback effects of estrogen include in vitro studies which
show that estrogen enhances both basal and GnRH induced LH
release (Tang et al 1982; Greeley et al 1975; Drouin and
11 -
Labrie 1981; Drouin et al 1976). There have also been reports
of ovarian steroid binding sites located intracellularly
(Stumpf 1971) and on rat pituitary membranes (Bression 1986).
There is some evidence which is compatible with the idea
that the "priming" effect of GnRH on gonadotropes may be
mediated by peptides which are regulated within the AP.
Exposure of the rat AP gland in vivo to low (doses too low to
produce a detectable increase in plasma LH) continuous
concentrations of GnRH or to small pulses of GnRH can result
in a surge of LH which is similar in magnitude to the
spontaneous ovulatory surge of LH (Fink et al 1976). This
phenomenon is known as the priming effect of GnRH and
demonstates how small pulses of GnRH could produce an
ovulatory surge of LH. Studies on the mechanism of the
priming effect have been done using short term incubations of
hemipituitary glands (Pickering and Fink 1976). These studies
showed that there are major differences between the releasing
action and the priming action of GnRH. The priming action of
GnRH develops at an age at least 12 days after the onset of
the releasing action of GnRH. The priming action is enhanced
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by estrogen and does not depend on extracellular Ca++ but is
dependent on protein synthesis and the integrity of the
microfilaments. Several experiments showed that the new
protein synthesized as part of GnRH priming is not LH
1 -
(Pickering and Fink 1979), but rather a protein with a
molecular weight (MW) of about 69, 000 (Curtis, Lyons and Fink
1984) which may be related to the hypothalamic estrogen
stimulated 70, 000 MW protein thought to be a heat shock
protein. Heat shock proteins are highly conserved throughout
evolution and are thought to be the forerunners to specific
cell surface receptors. Solubilized AP membranes subjected to
pOlyacrylamide gel electrophoresis after exposure to
radiolabeled SP results in a radiolabeled band determined to
be 70, 000 MW which is not seen in the presence of unlabeled
SP (preliminary findings, data not shown). This protein was
later found to be a heat shock protein (Barry Oblas, personal
communication) this would suggest that can bind
specifically to heat shock proteins. There also synthesis
of an 87 000 MW protein stimulated by GnRH incubation of
dispersed piuitary cells. It is tempting to speculate that
these newly synthesized proteins may be heat shock type
proteins which may act as receptors for regulatory peptides.
How do the results presented in this thesis relate to
the control of LH release in normal intact female rats? In 
cells from normal random cycling female rats SP causes a
significant stimulation of LH release. The finding that SP is
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effective in stimulating LH release in pituitary cell
cultures from adult females but not adult males implicates
this peptide as a possible intrapituitary regulatory factor
for variant LH secretion. The preponderance of evidence
suggests both negative and positive feedback actions of
estrogen can be exerted at the level of the anterior
pituitary gland and suggests that there are mechanisms at
that level to regulate the amount of LH released other than
decreased or increased sensitivity to GnRH, which depends in
large part on GnRH up regulation or down regulation of its
own receptor. Although GnRH stimulates LH release in both
male and female pituitaries, differences in LH secretion
i . patterns exist. It has been demonstrated using a pituitary
cell culture system that there is a sex difference in LH
release in response to GnRH stimulation (Tang, 1978). The
results demonstrate the ability in female rat pituitary
cultures to release a significantly greater percentage of
total LH in response to GnRH, and suggest that this may
provide the essential mechanism required for the preovulatory
, '
LH surge, whereas the lower response in the male may be
sufficient for tonic LH secretion.
Another intrapituitary mechanism independent of GnRH
which increases LH release and where SP may play a role is
the employment of different mechanisms for release of newly
synthesized and stored pools of the hormone. Ramey and
colleagues (1987) have reported that estradiol sensitizes the
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gonadotroph to GnRH for stimulation of LH biosynthetic
processes and that regulation of the release of newly
synthesized LH is different from that for previously stored
LH. They report that the differences in GnRH stimulated LH
synthesis caused by the estrogen environment could not fully
account for differences in GnRH stimulated LH release.
Therefore, it would seem that estrogen has separate effects
on the mechanisms regulating GnRH stimulated LH release and
LH biosynthesis. Conclusions by Ramey and Liu and Jackson
(1979) suggest that there are two pools of LH, and that under
non GnRH- stimulated conditions newly synthesized LH accounts
for a relatively greater percentage of the total LH released
compared to that released in response to GnRH, suggesting
that there may be more than one mechanism of release. Hiatt
and Schwartz (1989), in a recent study of basal LH secretion
from pituitary fragments taken at different stages of the
estrus cycle, demonstrate that in the presence of an
antagonist to GnRH, basal LH secretion is higher in proestrus
pituitaries than in metestrus pituitaries, suggesting that
there may be a higher basal release independent of GnRH
stimulation at proestrus. My results are consistent with the
possibility that SP may be an active substance, released in
response to an unknown physiological stimulus, acting in a
paracrine or autocrine fashion to stimulate an augmented
release of LH in females. This putative mechanism would be
particularly important at the time of the LH surge. One
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future experiment will involve comparing the sensitivity of
24 hour cultures of AP cells from female rats at different
stages of the estous cycle to determine whether there are
cycle differences in the ability of SP to stimulate LH
release.
Stimulation of LH Release by in Male Rats
AP cell cultures from the adult male rat are
significantly less sensitive to SP, although SP
concentrations in the adult male AP are 2 to 3-fold higher
than in the female rat AP. The higher concentration of SP, if
the peptide is released basally, could act to desensitize the
AP to SP. Binding studies described here, which show a
decrease in the number of SP receptors in the AP membranes of
male rats, would be consistent with this hypothesis. Future
experiments will focus on this question by attempting to
desensitize responding AP cells from female rats by a
constant exposure of cells to low doses of SP.
In the present study AP cell cultures from adult male
rats were less sensitive to exogenous SP than were AP cells
from adult females. The present results and other studies
demonstrate SP binding in both male and female rats
(Larsen, 1989; Kerdelhue, 1985). Results of the present SP
133
binding study show that SP receptors have an 8-fold lower
capacity in the male than in the female, this could be the
result of an 8-fold difference in the number of cells which
have binding sites for SP, nevertheless the end result is
more receptors in the female and a more sensitive response in
the female as measured by LH release from AP cells. These
findings are compatible with the presence of spare receptors
in the AP glands of female rats allowing for an increased
sensitivity to lower doses of SP.
Alternatively, SP binding in the male may be uncoupled
to a physiological second messenger stimulating LH release or
perhaps is coupled to a different signal system. It remains a
distinct possibility that in vivo there could be some
mechanism to inhibit binding or that there could be two
distinct types of SP receptor in the pituitary the ratio of
which could be regulated by the gonadal steroid environment
and which are obscured by in vitro methods of analysis.
Improved techniques in manipulating the steroid environment
and increased sensitivity in SP binding studies in the
anterior pituitary will aid in the attempts to answer these
questions.
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stimu ation of LH ease. during puberty
The development of responsiveness to SP in AP cell
cultures from both males and females closely parallels the
onset of puberty. The results of the present study
demonstrate that SP stimulation of LH secretion varies as a
function of age and sex. Before puberty AP cells from both
males and females are unresponsive to SP. However at 30-
days of age there is a steep increase in SP stimulated LH
release in both sexes. This response continues in the female
until sexual maturity and at all ages studied. In contrast to
these results AP cells from males failed to respond after 40
days of age and remained relatively unresponsive throughout
maturity at all ages studied.
The onset of puberty involves a complex array of
neuroendocrine regulatory mechanisms. The first hormonal
signal begins after 28 days of age. In the female rat a
diurnal pattern of LH release starts around day 30 in which
both basal LH levels and LH pulse amplitude are greater in
the afternoon than in the morning. These augmented afternoon
pulses result in significantly more estrogen and progesterone
release from ovaries in vitro (Ojeda and Urbanski, 1988). In
some rats afternoon minisurges of LH occur at this time. The
LH minisurges are estrogen dependent whereas the increase in
LH pulse amplitude is estrogen independent and thought to be
centrally driven (Urbanski and Ojeda, 1987). The increase in
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basal LH release during the peripubertal period has been
studied in the rhesus monkey (Teresawa et aI, 1984). It was
found that the amplitude of the difference in LH levels
between evening and morning in ovariectomized animals was
greatest when basal LH reached its highest level, which
occured immediately before the first ovulation. They note
that first ovulation occurs when all of the LH parameters,
including basal LH release, circadian LH fluctuations,
pulsatile LH, and biological activity of LH are maximally
active. SP could be contributing to this maximal LH output
effort by acting in a paracrine or autocrine way to stimulate
basal LH release at the time of puberty leading to first
ovulation.
Much less is known regarding the mechanisms controlling
puberty in the male rat. There have been conflicting reports
on LH secretion in the peripubertal male, some reporting
enhanced and others reporting decreased LH secretion during
this period. The inconsistancy probably arises because of the
pulsatile manner of LH release at this time. In the present
study the response to SP in peripubertal males was highly
variable and may reflect the rapid changes occurring in the
secretory patterns of LH during peripubertal maturation.
Brown-Grant (1976) claims that the prepubertal rat is a bad
model for the study of LH secretion and cites studies of
several researchers who report wide variability in both
baseline and stimulated LH concentrations in plasma which
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could only be reduced by using large numbers of rats or
pooling serum from several rats. Only with these measurements
have meaningful trends been established for the developmental
1=:
changes in LH secretion in pubertal and prepubertal male
rats.
It remains to be established whether changes in the
pattern of LH secretion play a role in modulating prepubertal
steroidogenesis in the male. It is clear from the present
study that AP cells from peripubertal males release LH in
response to SP and that this occurs only during the period of
puberty in the male rat. It could be postulated that this
mechanism allowing for augmented LH release is needed at this
time to initiate and fine tune steroidogenesis of the testes.
GnRH stimulation has been shown to result in the release of
stored hormone preferentially, whereas secretion of newly
synthesized hormone is thought to be regulated differently
(Ramey et aI, 1987). The paracrine action of SP could provide
a mechanism for release of a larger percentage of total
hormone than that which would be released upon GnRH
stimulation alone.
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Summary Conclusions
The results of the present study show:
1. SP can have an effect on LH release by acting directly on
AP cells in culture.
2. The effect of SP on LH release is dependent on the sex of
the rat from which the AP cells were prepared.
3. The effect of SP is dependent on the age of the rat from
which the AP cells were prepared.
4. There are specific binding sites for SP on AP membranes.
5. Certain characteristics of SP binding correlate with the
bioactivity of SP.
There is no doubt that a great number of questions have
been raised as a result of this research. These studies will
serve as a stimulus to embark on an entirely new avenue of
research on the role of SP in the regulation of LH secretion.
The direction that future studies will take will be to
investigate further the underlying basis for the sex
differences in the stimulation of LH secretion from AP cells
in culture by SP, differences that are due to maturational
processes and to various other endocrine changes.
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